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11.INTRODUCTION (www.DrugstoreTM.com)
Medicine is considered as one of major important necessity to all of us. It is
derived from the Latin words as medicine meaning "the art of healing".  It is a branch
of health sciences and is the sector of public life concerned with maintaining or
restoring human health through the study, diagnosis, treatment and possible
prevention of disease, injury and other damage to the body or mind. It is both an area
of knowledge, a science of body system and their diseases and treatment. This branch
of science encompasses treatment by drugs, diet, exercise and other nonsurgical
means. It is also used to maintain our health. An agent such as drug is used to treat
disease or injury.
In the field of Pharmacology, potency is a measure of the drug activity
expressed in terms of amount required to produce an effect of given intensity. A
highly potent drug evokes a larger response at low concentrations, while a drug of
lower potency evokes a small response at low concentrations. It is proportional to
affinity and efficacy.
To demonstrate potency using an analytical assay as a surrogate measurement
of biological activity, one should provide sufficient data to establish a correlation
between the surrogate measurement(s) and the biological activity (ies) that is related
to potency. The relationship between the surrogate measurement and biological
activity may be established using various approaches, which includes comparison to
preclinical/proof of concept data, in vivo animal or clinical data, or in vitro cellular or
biochemical data. While choosing to use an analytical assay as a surrogate
measurement of biological activity to meet the potency requirements for licensed
biological products, you should meet criteria. The ability to measure potency is very
2essential to product characterization; one should initiate potency assay development
during preclinical and early clinical investigations to obtain as much product
information as possible.
In addition, measuring drug potency during early product development has a
number of advantages, such as:
 Demonstrate product activity, quality and consistency throughout product
development
 Generate a collection of data to support specifications for lot release
 Provide a basis for assessing manufacturing changes
 Evaluate product stability
 Evaluate multiple assays
 Recognize technical problems or reasons a different assay might be preferable
Presently drug analysis and Pharmaceutical impurities are the subjects of
constant review in the public interest. The International Conference of Harmonisation
(ICH) guidelines achieved a great deal in harmonizing the definition of impurities in
new drug substances. It is necessary to perform all the investigations on appropriate
reference standards of drug and impurities to get meaningful specifications. In order
to meet the challenges to ensure high degree of purity of drug substances and drug
products a scheme is proposed for profiling drug impurity. Finally analytical methods
based on analytical Instrumentation must be employed to quantitate drug substance
and its impurities.
31. 1 ANALYTICAL CHEMISTRY (Devala rao G., 2008; Khare R.P., 2007)
Analytical chemistry may be defined as the science and art of determining the
composition of materials in terms of the elements (or) compounds contained. In
analytical chemistry it is prime importance to gain information about the qualitative
and quantitative composition of substances and chemical species
Introduction to analytical methods brought a drastic change, in which physical
property of a substance is measured to determine its chemical composition. An
analysis instrument is a device (or) a set of devices that acquires the desired
information regarding the chemical composition (or) the physical properties of a
given sample (or) the process. This information may be required for a variety of
purposes, eg: testing of materials, maintenance of standards, verification of physical
phenomena, monitoring the process stream, controlling product quality safety
management and so on. Analysis instrumentation is the science of technology of
developing such measuring devices. Analytical chemistry including quantitative
analysis is of enormous importance in science and industry. Chemical analysis is a
most important method of investigation and it is widely used in all branches of
sciences which are related to chemistry. At present no material is taken into
production or released into the market without analytical data which characterize its
quality and suitability for various purposes. Analysis of intermediate products is of
enormous importance. The qualitative analysis gives us the information about the
nature of sample by knowing about the presence or absence of certain components.
4Aims and objectives of analytical chemistry (kellner R., 2004)
Analytical chemistry has two main aims (intrinsic and extrinsic). The intrinsic
aim is the achievement of the metrological activity i.e ensuring full consistency
between the analytical results delivered and the actual value of the measured
parameters. The extrinsic aim is solving the analytical problems derived from the
(bio)chemical information needs posed by a variety of ‘clients’(eg private companies,
social agents, research centers) or, in other words, providing client satisfaction.
Broadly speaking the principle objective of the analytical chemistry is to obtain as
much (bio)chemical information and of as high quality as possible from objectives
and systems by using as little material, time human resources as possible and with
minimal costs and risks.
APPLICATIONS OF ANALYTICAL CHEMISTRY TO VARIOUS BRANCHES
Analytical chemistry theory practice R.M. Verma
Analytical chemistry plays a very significant role in chemical research as every
chemist uses directly data obtained by applying techniques. Apart from applications to
chemical research, analytical techniques are frequently employed in industry in
connection with problems such as, quality control and in ascertaining most
appropriate experimental conditions for obtaining maximum yield of a particular
product. It should be noted that techniques of analytical chemistry find wide
application not only in different branches of chemistry but also in other physical and
biological sciences and in many fields of engineering.
Geologists are analytical procedures for analyzing ground water, minerals,
rocks, ores etc... In agriculture, chemical analysis is used to determine the
composition of soils, in the production of fertilizers, insecticides and weed killers.
5Medical and biological research programmes depend on chemical analysis which
helps in    developing medicines to cure various diseases.
In order to safeguard public health there is constant checking of foods, drugs,
cosmetics, water supplies etc., and this is done in analytical laboratories. Waste
disposals and the composition of air in industrial areas are analysed to know the
extent of harm they would cause to public health, so that necessary preventive steps
can be   taken.
Analytical methods (P C Kamboj, 2003. Annees A. Siddiqui, 2006)
The pharmaceutical analysis defined as “the branch of practical chemistry
which deals with the resolution, separation, identification, determination and
purification of a given sample of a medicine, the detection and estimation of
impurities, which may be present in drug substance (or) given sample of medicine”.
The substance may be a single compound or a mixture of compounds and may
be in the form a tablet, pill, capsule, ampoule, liquid, mixture or an ointment.
The quality control tests involve methods which embrace chemicals,
physio -chemical/ instrumental, microbiological (or) biological procedures.
The pharmaceutical analysis deals with the subject of determining the
composition of material in terms of the elements or compound (drug) present in the
system.
Any type of analysis involves two steps
Identification (qualitative)
Estimation (quantitative)
In qualitative analysis, a reaction is performed in such a way as to indicate the
formation of a precipitate, a change of a colour, the dissolution of a precipitate/
complex formation and the evaluation of a gas.
6Quantitative analysis is performed ordinarily through five steps. They are
sampling, dissolution, precipitation, measurement and calculation.
Method of assay
It indicates the quantitative determination of principal ingredients of the
official substances and in preparations.
Qualitative analysis
This is practiced in order to establish the composition of a naturally occurring or
artificially synthesized/ manufactured substance.
Qualitative analysis
I. Chemical Methods
a) Titrimetric analysis
b) Gravimetric analysis
c) Gasometric analysis
II. Physio - Chemical Methods (Instrumental Methods)
III. Microbiological Procedures
IV. Biological Procedures
I. Chemical Methods
a. Titrimetric Analysis
The analysis based on the fact that in all balanced chemical reactions utilized
for the purpose. Equivalent weight of one substance reacts quantitatively with the
equivalent weight of the other substance. The difference types of titration are as
follows
Acid base titrations (neutralization titrations)
Non- aqueous titrations
Redox titrations (redox = oxidation - reduction)
7Precipitation titrations
Complexometric titrations
b. Gravimetric Analysis
This method involves the conversion of the element or a radical to be
determined into a pure stable compound readily convertible into a form suitable for
weighing.
c. Gasometric Analysis
This type of analysis involves the measurement of the volume of gases. The
volume of a gas set free in a given chemical reaction under the conditions similar to
those described in the process. It may be noted that the volume of gas is taken at
normal conditions and pressure or standard temperature and pressure (NTP/ STP)
which is a temperature of 00C (273.09o K) and the pressure of a column of 760mm/
Hg at 00C. If the reaction is taken place under different temperature and pressure the
volume is adjusted to standard conditions. A decrease in the volume of gas when a
suitable reagent is placed to absorb one of the gases present. This decrease in volume
is also reduced to STP.
The gases cyclopropane, CO2, NO2, oxygen, octyl nitrite, Nitrogen,
amyl nitrite, ethylene and helium are determined by gasometric analysis. The
measurement of volume of gases is usually done by means of gas burettes or
nitrometers.
II. Physio - Chemical Methods (Instrumental Methods)
Initially analytical methods were depending on extraction procedure,
volumetric and gravimetric methods. All these methods are nearly replaced by
advanced instrumental methods. These methods are more sensitive, specific and
accurate but cost factors of the instruments and their maintenance are the main draw
8backs. Various instrumental methods are classified depending on the property
analyzed.
Shows different Instrumental methods with basic principle
Sr. N0. METHOD BASIC PRINCIPLE
A ELECTROANALYTICAL METHODS
1 Potentiometry
Concerned with change in electrical
properties of the system measures the change
in electrode potential during a chemical
reaction of the system
2 Conductometry Measures the change in electricalconductivity during a chemical reaction
3 Polarography
Measure the current at various applied
potential indicating the polarization at
indicator electrode
4 Amperometry Measure the change (or decrease) in currentat a fixed potential during addition of titrant
B SPECTROSCOPIC METHODS
1
Absorption Spectroscopy
(Ultraviolet-Visible and
Infrared)
Measure the absorbance or percent
transmittance during the interaction of
monochromatic radiation (or particular
wavelength) by the same
2 Fluorimetry
Measure the intensity of fluorescence caused
by emission of electromagnetic radiation due
to absorption of UV radiation
3 Flame Photometry
Measure the intensity of emitted light of
particular wave length emitted by particular
element
94 Turbidimetry Measure the turbidity of a system by passinglight beam in a turbid media
5 Nephlometry Measure the opalescence of the medium byreflection of light by a colloidal solution
6 Atomic AbsorptionSpectrometry
Measure the intensity of absorption when
atoms absorbs the monochromatic radiation
7 X-Ray Spectroscopy
Measure the position and intensity of
spectral lines during emission of X ray
spectrum by atoms under influence of X rays
8 Refractometry Measure the refractive index by causingrefraction of light by matter
9 Polarimetry Measure optical reaction by causing therotation of plane polarized light
C Mass Spectroscopy
Observe the position and intensity of signals
in mass spectrum by causing the ionization
of molecules
D NMR Spectroscopy
Observe the position and intensity lines in
NMR spectrum when proton interact with
electromagnetic radiation in radio frequency
region
E Thermal Methods
Measure the physical parameters of the
system as a function of temperature. It
includes thermo gravimetry, derivative
gravimetry, differential thermal analysis
F Radiometric Methods Measure the radioactivity either presentnaturally or induced artificially
10
III. Microbiological Methods
`In a microbiological assay, a comparison of inhibition of the growth of
bacteria by a measured concentration of the antibiotic, which is to be examined, is
made with that produced by known concentration of the standard preparation of an
antibiotic having known activity.
IV. Biological Methods
When the potency of a drug or its derivative cannot be properly determined by
physical or chemical methods and where it is possible to observe the biological effects
of the drug on some type of living matter. The biological assays are carried out. The
basis of such assay is to determine how much of the sample gives the same biological
effect as a given quantity of the standard preparation. The sample and standard
preparation are tested under identical conditions in all respect. In a typical bio – assay,
a stimulus is applied to a subject is referred to as the dose and is indicated by a weight
or in terms of the concentration of the preparation. The application of stimulus on a
subject produces some observable effect and this is called the response. The response
may be measured by the total weight or weight of some organ of the subject, blood
sugar concentration, and diameter of inhibition zone or by some other physiological
symptoms.
11
1.2 ULTRAVIOLET SPECTROSCOPY (Beckett A.H and stenlake J.B., 2002)
Ultraviolet spectroscopy deals with the measurement of energy absorbed when
electrons are promoted to higher energy state. On passing electromagnetic radiation in
the ultraviolet and visible regions through the compound with multiple bonds, a
portion of the radiation is normally absorbed by the compound. The amount of
absorption depends on the wavelength of the radiation and the structure of the
compound. Absorption of the electromagnetic radiation in the visible and ultraviolet
region of spectrum results in changes of electronic structure of ions and molecules.
Diagram of an Analytical instrument showing the stimulus and
measurement of response.
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QUANTITATIVE SPECTROPHTOMETRIC METHODS
(Beckett and Stenlake, 2002)
The assay of an absorbing substance may be quickly carried out by preparing a
solution in a transparent solvent and measuring its absorbance at a suitable
wavelength. The wavelength normally selected is a wavelength of maximum
absorption (max), where small errors in setting the wavelength scale have little effects
on the measured absorbance.
a. Assay of substances in single component samples
Absorption spectroscopy is one of the most useful tools available to the
chemist for quantitative analysis. The most important characteristics of photometer
and spectrophotometric method are high selectivity and ease of convenience.
Quantitative analysis (assay of an absorbing substance) can be done using following
methods.
- Use of values
- Use of calibration graph (multiple standard method)
- By single or double point standardization method.
i) Use of values
This method can be used for estimation of drug from formulations or raw
material, when reference standard not available. The use of standard value
avoids the need to prepare a standard solution of the reference substance in order to
determine its absorptivity, and is of advantage in situations where it is difficult or
expensive to obtain a sample of the reference substance.
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ii. Use of calibration graph
In this procedure the absorbances of a number (typically 4-6) of standard
solutions of the reference substance at concentrations encompassing the sample
concentrations are measured and a calibration graph is constructed. The concentration
of the analyte in the sample solution is read from the graph as the concentration
corresponding to the absorbance of the solution. Calibration data are essential if the
absorbance has a non-linear relationship with concentration, or if the absorbance or
linearity is dependent on the assay conditions. In certain visible spectrophotometric
assays of colourless substances, based upon conversion to coloured derivatives by
heating the substance with one or more reagents, slight variation of assay conditions,
e.g. PH, temperature and time of heating, may rise to a significant variation of
absorbance, and experimentally derived calibration data are required for each set of
samples.
iii. Single or double point standardization
The single point procedure involves the measurement of the absorbance of a
sample solution and of a standard solution of the reference substance. The standard
and the sample solution are prepared in similar manner; ideally the concentration of
the standard solution should be close to that of the sample solution. The concentration
of the substance in the sample is calculated using following formula.
Ctest = A test × Cstd / Astd
Where,
Ctest and Cstd are the concentration in the sample and standard solutions
respectively.
Atest and Astd are the absorbance of the sample and standard solutions
respectively.
14
In double point standardization, the concentration of one of the standard solution
is greater than that of the sample while the other standard solution has a lower
concentration than the sample. The concentration of the substance in the sample
solution is given by
(Atest – Astd1)(Cstd1-Cstd2) +Cstd1 (Astd1-Astd2)
Ctest =
Astd1-Astd2
Where,
Cstd is the concentration of the standard solution.
Atest and Astd are the absorbance of the sample and standard solution
respectively.
Std1 and std2 are the more concentrated standard and less concentrated
standard respectively.
b. Assay of substances in multi component samples
The spectrophotometric assay of drugs rarely involves the measurement of
absorbance of samples containing only one absorbing component. The pharmaceutical
analyst frequently encounters the situation where the concentration of one or more
substances is required in samples known to contain other absorbing substances which
potentially interfere in the assay. Unwanted absorption from these sources is termed
irrelevant absorption and if not removed, imparts systematic errors to the assay of the
drug in the sample. A number of modifications to the simple spectrophotometric
procedure for single-component samples are available to the analyst, which may
eliminate certain sources of interferences and permit the accurate determination of
one or all of the absorbing components.
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The basis of all the spectrophotometric technique for multicomponent samples
is the property that at all wavelengths:
a) The absorbance of a solution is the sum of absorbances of the
individual components; or
b) The measured absorbance is the difference between the total
absorbance of the solution in the sample cell and that of the solution
in the reference (blank) cell.
The determination of the multi-component samples can be done by using the
following methods,
 Simultaneous equation method
 Absorbance ratio method
 Geometric correction method
 Orthogonal polynomial method
 Difference spectrophotometry
 Derivative spectrophotometry
 Chemical derivatisation
1.2.1 Methods carried out
i. SIMULTANEOUS EQUATION METHOD
ii. AREA UNDER THE CURVE METHOD
iii. DERIVATIVE SPECTROSCOPIC METHOD
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i. SIMULTANEOUS EQUATION METHOD
If a sample contains two absorbing drugs (X and Y) each of which absorbs at
λ max of the others it may be possible to determine both drugs by the technique of
simultaneous equation (Vierodt’s method) provided that criteria apply.
Information required is
1. The absorptivities of X at λ1 and λ2 are ax1 and ax2, respectively
2. The absorptivities of Y at λ1 and λ2 are ay1 and ay2, respectively
3. The absorbances of the diluted sample at λ1 and λ2, A1 and A2 respectively.
Let cx and cy be the concentrations of X and Y respectively in the diluted sample.
Two equations are constructed based upon the fact that at λ1 and λ2
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Criteria for obtaining maximum precision, based upon the absorbance ratios,
have been suggested (Glenn, 1960) that place limits on the relative concentrations of
the components of the mixture. The criteria are the ratios.
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Should lie outside the range 0.1-2.0 for the precise determination of X and Y
respectively. These criteria are satisfied only when the λ max of the two components is
reasonably dissimilar. An additional criterion is that the two components do not
interact chemically, there by negating the initial assumption that the total absorbance
is equal to sum of the individual absorbances.
ii. AREA UNDER THE CURVE METHOD (Telekone et al., 2010)
The area under curve method is applicable where there is no sharp peak or
when broad spectra are obtained. It involves the calculation of integrated value of
absorbance with respect to the wavelength between the two selected wavelengths λ1
and λ2. Area calculation processing item calculates the area bound by the curve and
the horizontal axis. The horizontal axis is selected by entering the wavelength range
over which area has to be calculated. This wavelength area is selected on the basis of
repeated observation so as to get the linearity between area under curve and
concentration.  In combination drugs λ1 and λ2 denotes the wavelength ranges of the
components. The integrated value of absorbance in the wavelength ranges of both the
18
drugs are substituted in the simultaneous equation to get the concentration of the
drugs.
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iii. DERIVATIVE SPECTROSCOPIC METHOD
This method involves the conversion of the normal spectrum into first, second or
higher derivative spectrum. The transformation that occurs in the derivative spectrum
is understood by reference to a Gaussian band which represents an ideal absorption
band.
The first derivative (D1) spectra is a plot of the ratio of change of absorbance with
wavelength  against wavelength, i.e a plot of slope of the fundamental spectrum
against wavelength or a plot of  dA/dλ Vs λ1. At λ2 and λ4, the maximum positive and
maximum negative slope respectively in the D°. Spectrum corresponds with
maximum and minimum respectively in the D1 spectrum. The λmax at λ3is a
wavelength of zero slope and gives dA/dλ, i.e a cross-over point, in the D1
spectrum.
The first order derivative spectrum of absorption band is characterized by a
maximum, a minimum and a cross-over at a λmax of the absorption band. These
spectral transformations confer two main advantages on derivative
spectrophotometry. Firstly an even order spectrum is of narrower spectral band width
than its fundamental spectrum.
Derivative spectrum shows better resolution of overlapping bands than the
fundamental spectrum and may permit the accurate determination of λmax of the
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individual bands. Secondly, derivative spectroscopy discriminates in favours of the
substances of narrow spectral bandwidth against broad band width substances.
The absorption laws (Y.R. Sharma, 2009)
There are two laws which govern the absorption of light by the molecules.
These are,
(1) Lambert’s Law
(2) Beer’s Law
Lambert’s Law
When a beam of monochromatic radiation passes through a homogenous
absorbing medium, the rate of decrease of intensity of radiation with thickness of
absorbing medium is proportional to the intensity of incident radiation.
I = I0e-kt
Where, I0 = Intensity of incident light
I = Intensity of emerged light
t = Thickness of the medium
Beer’s Law
When a beam of monochromatic radiation is passed through a solution of an
absorbing substance, the rate of decrease of intensity of radiation with concentration
of the absorbing solution is directly proportional to the intensity of incident radiation.
I = I0e-kc
Where, I0 = intensity of incident light
I = Intensity of emerged light
c = concentration of the absorbing species
From these laws, the following empirical expression of Beer - Lambert’s Law was
constructed
20
Log (I0/IT) = Єct =A
Where, A= Absorbance or optical density or extinction co-efficient
Є = Molecular extinction co-efficient
c = Concentration of drug
t = Path length
Limitations of Beer Lambert’s Law
1. When different forms of the absorbing molecules are in equilibrium as in
keto-enol tautomers.
2. When fluorescence compounds are present.
3. When solute and solvent forms complex through some sorts of association.
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1.3 INTRODUCTION TO HPLC METHODS OF ANALYSIS OF DRUGS IN
COMBINED DOSAGE FORM (Chatwal R Gurdeep, et al., 2008)
High performance liquid chromatography [HPLC] was developed in the late
1960’s and 1970’s it is widely accepted separation technique for both sample analysis
and purification in a variety of areas including the pharmaceutical, biotechnological,
environmental polymer and food industries.
HPLC instrumentation is made up of eight basic components they are
mobile phase reservoir, solvent delivery system, sample introduction device, column,
detector, waste reservoir, connective tubing and a computer, integrator (or) recorder.
Chromatography is defined as a method of separating a mixture of
components into individual components through equilibrium distribution between two
phases. Chromatography technique is based on the difference in the rate at which the
components of a mixture move through a porous medium (stationary phase) under the
influence of some solvent or gas (mobile phase).
The chromatographic method of a separation in general involves the following
steps:
Adsorption or retention of a substance or substance on the stationary phase.
Separation of the adsorbed substance by the mobile phase.
Recovery of the separated substance by a continuous flow of the mobile phase.
The method being called elution.
Quantitative and qualitative analysis of the eluted substance
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1.3.1 Introduction to HPLC (Sharma B K., 2006)
HPLC is a form of liquid chromatography to separate compounds that are
dissolved in solution. HPLC instrument consists of four basic parts
 The column
 Detector
 Injection system
 Mobile-phase pump system
A schematic diagram of HPLC equipment
1.3.2 Principle of separation in HPLC (Willard et al., 1986)
The principle of separation in normal phase and reverse phase mode is the
adsorption. When a mixture of components is introduced in to a HPLC column, they
travel according to their relative affinities towards the stationary phase. The
component which has more affinity towards the adsorbent travels slower. The
components which have less affinity towards the stationary phase travel faster. Since
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no two components have the same affinity towards the stationary phase the
components are separated.
1.3.3 Modes of chromatography
i. Normal phase mode
ii. Reverse phase mode
i. Normal phase chromatography
In normal phase mode, the stationary phase (silica gel) is polar in nature and
the mobile phase is non-polar. In this technique non-polar compounds travel faster
and eluted first. The silica structure is saturated with silicon groups at the end and
‘OH’ groups attached to silicon atoms are the active binding sites.
ii. Reverse phase chromatography
In reverse phase technique, a non polar stationary phase is used. The mobile
phase is polar in nature hence polar components get eluted first and non-polar
compounds are retained for a longer time. Since most of the drugs and pharmaceutical
are polar in nature, they are not retained for a longer and eluted faster, which is
advantageous. Different columns used are ODS (octadecyl silane) or C18, C8 and C4
etc.
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1.4 ICH GUIDELINES FOR ANALYTICAL METHOD VALIDATION
(Code Q2A; Q2B. ICH Guidelines1994 and 1996)
Method validation is the process to confirm that the analytical procedure
employed for a specific test is suitable for its intended use. Methods need to be
validated or revalidated. The International Conference of Harmonization (ICH) of
technical requirements for the registration of pharmaceutical for human use has
developed a consensus text on validation of analytical procedures. The document
includes definition for eight validation characterstics.
The parameters as defined by the ICH and by other organizations
 Specificity
 Selectivity
 Precision
 Repeatability
 Intermediate precision
 Reproducibility
 Accuracy
 Linearity
 Range
 Limit of detection
 Limit of quantification
 Robustness
 Ruggedness
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1.4.1 SPECIFICITY
Specificity is the ability to assess unequivocally the analyte in the presence of
components which may be expected to present. An investigation of specificity should
be conducted during the validation of identification tests, the determination of
impurities and assay.
1.4.2 ACCURACY
The accuracy of an analytical procedure expresses the closeness of
agreement between the value which is accepted either as a conventional true value or
on an accepted reference value and the value found.
1.4.2.1 Assay
- Assay of Active substances
- Assay of Medicinal products
Several methods are available to determine the accuracy
a) Application of an analytical procedure to an analyte of known purity
b) Comparision of the results of the proposed analytical procedure
c) Application of the analytical procedure to synthetic mixtures
1.4.2.2 Impurity (Quantification)
Accuracy should be assessed on sample spiked with known amounts of
impurities. It should be clear how the individual or total impurities are to be
determined.
Eg: weight/weight or area percent
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1.4.3 PRECISION
The precision of an analytical procedure expresses the closeness of the
agreement between a series of measurements obtained from multiple sampling of
same homogeneous sample under the prescribed conditions. Validation of tests for
assay and for quantitative determination of impurities includes an investigation of
precision.
1.4.3.1 Repeatability (intra- assay precision)
Express the precision under small operating conditions over a short interval of
time. It should be assessed using a minimum of nine determinations.
1.4.3.2 Intermediate Precision
The extent to which intermediate precision should be established depends on
the circumstances under which the procedure is intended to be used. Typical
validation to be studied includes days, analysts, equipments, etc.
1.4.3.3 Reproducibility
Reproducibility is assessed by means of an inter-laboratory trail.
Reproducibility should be considered in case of the standardization of an analytical
procedure, for insistence inclusion of procedure in pharmacopoeias.
1.4.4 LINEARITY
Linearity of an analytical procedure is its ability (with in a given range) to
obtain test results which are directly proportional to the concentration (amount) of
analyte sample.
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1.4.5 RANGE
Range of an analytical procedure is the interval between the upper and lower
concentration of analyte in the sample including these concentrations for which it has
been demonstrated that the analytical procedure has a suitable level of precision,
accuracy and linearity.
1.4.6 LIMIT OF DETECTION
The detection limit is determined by the analysis of samples with known
concentration of analyte and by establishing that minimum level at which the analyte
can reliably detected.
a. Based on visual evaluation
b. Based on Signal-to-Noise ratio
c. Based on the standard deviation of the response and the slope
 Based on the standard deviation of blank
 Based on the calibration graph
The detection limit (DL) may be expressed as
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S
3.3σDL
Where,
σ = standard deviation of the response
S= slope of the calibration curve (of the analyte)
1.4.7 LIMIT OF QUANTIFICATION
The quantification limit is generally determined by the analysis of samples
with the known concentrations of analyte and by establishing the minimum value at
which the analyte can be quantified with acceptable accuracy and precision
a. Based on visual evaluation
b. Based on Signal-to- Noise ratio
c. Based on the standard deviation of the response and the slope
 Based on the standard deviation of blank
 Based on the calibration graph
The quantification limit may be expressed as,
S
10σQL
Where,
σ = standard deviation of the response
S = slope of the calibration curve (of the analyte)
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1.4.8 ROBUSTNESS
The evaluation of robustness should be considered during the development
phase and depends on the type of procedure under study. It shows the reliability of an
analysis with respect to deliberate variations in the method parameters.
1.4.9 RUGGEDNESS
The united states of pharmacopoeia (USP) define ruggedness as the degree of
reproducibility of test results obtained by the analysis of the same sample under a
variety of normal test condition such as different labs, different analysis, different lots
of reagents etc. Ruggedness is a measure of reproducibility of test results under
normal expected operational conditions from laboratory to laboratory and from
analyst to analyst.
1.5 SYSTEM SUITABILITY PARAMETERS
(anonymous. USP, 1995; Sethi 2001)
System suitability test are an integral part of gas and liquid chromatography.
They are used to verify that the resolution and reproducibility of the chromatographic
system are adequate for the analysis to be done. These tests are based on the concept
that the equipment, electronics, analytical operations and samples to be analysed
constitute an integral system that can be evaluated as such. FDA guidelines on
“validation of chromatographic methods” the following acceptance limits are
proposed as initial criteria.
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System suitability parameters and recommendations
S.No. Parameters Recommendations
1 Theoritical plates (N) >2000
2 Tailing factor (T) ≤ 2
3 Assymetric factor ≤ 2
3 Resolution (Rs) > 2 between peak of interest and the closest
eluting potential interference
4 Repeatability RSD ≤ 1% for N ≥5 is desirable
5 Capacity factor (k1) > 2.0
6 Relative retention Not essential as long as the resolution is stated
1) Capacity Factor (or) Retention (KA)
The retention of a drug with a given packing material and eluent can be
expressed as retention time or retention volume, but both of these are dependent on
flow rate, column length and column diameter. The retention is best described as a
column capacity ratio (K), which is independent of these factors. The column capacity
ratio of a compound (A) is given as
0
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2) Resolution (RS)
The resolution, Rs of two neighboring peaks is defined by the ratio of the
distance between the two peak maxima. It is the difference between the retention
times of two solutes divided by their average peak width. For baseline separation, the
ideal value of Rs is 2.0. It is calculated by using the formula,
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Where,
Rt1 and Rt2 are the retention times of components 1 and 2
W1 and W2 are peak widths of components 1 and 2
3) Selectivity ()
The selectivity (or separation factor) , is a measure of relative retention of
two components in a mixture. The ideal value of selectivity is 2. It can be calculated
by using the formula,
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Where, V0 is the void volume of the column and V2 and V1 are the retention
volumes of the second and the first peak, respectively.
4) Column efficiency
Efficiency, N, of a column is measured by the number of theoretical plates per
meter. It is a measure of band spreading of a peak. Smaller the band spread, higher is
the number of theoretical plates, indicating good column and system performance.
Columns with N ranging from 5,000 to 1,00,000 plates/meter are ideal for a good
system. Efficiency is calculated by using the formula,
2
2
16 W
RtN 
Where, Rt is the retention time and W is the peak width.
5) Peak asymmetry factor (As)
Peak asymmetry factor, As can be used as a criterion of column performance.
The peak half width b of a peak at 10 % of the peak height, divided by the
corresponding front half width a gives the asymmetry factor.
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1.6 PHARMACEUTICAL STATISTICS
Linear regression
Linear regression a statistical technique that defines the functional relationship
between two variables by best-fitting straight line. Once a linear relationship has been
shown to have a high probability by the value of the correlation coefficient ‘r’, then
the best straight line through the data points has to be estimated. This can often be
done by visual inspection of the calibration graph, but in many cases it is far more
sensible to evaluate the best straight line by linear regression (the method of least
squares)
The equation of straight line is
y = mx + c
Where, y the dependent variable is plotted as result of changing x, the independent
variable.
To obtain the regression line ‘y on x’ the slope ‘m’ of the line and the intercept
‘c’ on the y axis are given by the following equation.
And
33
Correlation coefficient (r)
It is a procedure commonly used to characterize quantitatively the relationship
between variable. Correlation is related to linear regression. To establish whether
there is a linear relationship between two variables x1 and y1, use Pearson’s
correlation coefficient ‘r’.
Where n is the number of data points.
The value of ‘r’ must lie between +1 and -1, the nearer it is to +1, the greater
the probability that a definite linear relationship exists between the variables x and y,
values close to +1 indicate positive correlation and values close to -1 indicate negative
correlation values of ‘r’ that tend towards zero indicate that x and y are not linearly
related (they made be related in a non-linear fashion).
Standard deviation (SD)
It is commonly used in statistics as a measure of precision statistics and is
more meaningful than is the average deviation. It may be thought of as a root-mean-
square deviation of values from their average and is expressed mathematically as
Where,
S is standard deviation.
If N is large (50 or more) then of course it is immaterial whether the term in
the denomination is N -1 or N
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Σ       = sum
x = Mean or arithmetic average.
x-x = deviation of a value from the mean
N      = Number of observations
Percentage relative standard deviation (%RSD)
It is also known as coefficient of variation (CV). It is defined as the standard
deviation (S.D) expressed as the percentage of mean.
C 100x
S.DRSD%orV 
Where,
S.D is the standard deviation,
x = Mean or arithmetic average.
The variance is defined as S2 and is more important in statistics than S itself.
However, the latter is much more commonly used with chemical data.
Standard error of mean (SE)
Standard error of mean can be defined as the value obtained by division of
standard deviation by square root of number of observations. It is mathematically
expressed as
n
S.D.S.E.
Where, S.D = Standard deviation = number of observations.
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2. LITETRATURE REVIEW
2.1 DRUG PROFILE (The Indian pharmacopoeia 2007)
2.1.1 AMBROXOL HYDROCHLORIDE
Molecular structure
Chemical name
trans-4-[(2-Amino-3,5-dibromobenzyl)amino] cyclohexanol hydrochloride.
Molecular formula
C13H18Br2N2O.HCl
Molecular weight
414.6
Category
Mucolytic expectorant.
Description
A white or yellow crystalline powder.
Solubility
Ambroxol HCl is sparignly soluble in water, soluble in methanol, practically
insoluble in methylene chloride.
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Storage
Protect from light. Following reconstitution, aliquot and freeze at -20oC. This
product is stable for 2 years as supplied. Stock solutions are stable for 4 months at
-200C.
Identification
i) Melting point
Standard value Observed average value*
233 ºC -236ºC 234.66ºC
*Average of six observations
ii) Infra red spectrum
iii) Thin layer chromatography
Test solution – dissolve 50mg of the substance to be examined in methanol
and dilute to 5ml with the same solvent.
Reference solution – dissolve 50mg of Ambroxol HCl in methanol &
dilute to 5ml with the same solvent.
Plate – TLC silica gel F254 plate.
Mobile phase – con.ammonia, 1-propanol, ethyl acetate, hexane.
Drying in air.
Detection – examine in UV at 254nm.
Results – the principle spot in the chromatogram obtained with the test
solution is similar in position and size to the principle spot in the
chromatogram obtained with the reference solution.
PH
4.5 -6
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Mechanism of Action
The substance is a mucoactive drug with several properties including
secretolytic and secretomotoric actions that restore the physiological clearance
mechanisms of the respiratory tract which play an important role in the body’s natural
defense mechanisms. It stimulates synthesis and release of surfactant by type II
pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of
mucus to the bronchial wall, in improving its transport and in providing protection
against infection and irritating agents. Ambroxol HCl enhances penetration power of
antibiotics. Administration of Ambroxol together with antibiotics leads to higher
antibiotic concentration in the lung tissue. It also act as a scavenger of hypochlorous
and hydroxyl radicals, it blocks nitric oxide stimulated activation of guanylate cyclise.
Contraindications
Ambroxol should not be used in patients known to be hypersensitive to
Ambroxol or other components of the formulation
Ambroxol side effects
Occasional gastro intestinal side effects may occur but these are normally
mild.
Overdosage
No symptoms of overdosage have been reported in man to date. If they occur,
symptomatic treatment should be provided. Interactions Administration of Ambroxol
together with antibiotics (amoxicilline, cefuroxime, erythromycin, doxycycline) leads
to higher antibiotic concentration in the lung tissue. No clinically relevant unfavorable
interaction with other medications has been reported.
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2.1.2 CEFPODOXIME PROXETIL
Molecular structure (The Merck index 2006, 14th edition)
Chemical name
[6R-[6α,7β(z)]]-7-[[(2-amino-4-thiozolyl)(methoxyimino)acetyl]amino]-3-
(methoxy-methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid1-[[(1-
methyl ethoxy)carbonyl]oxy]ethyl ester.
Molecular formula
C21H27N5O9S2
Molecular weight
557.61
Category
Antibiotic:Used for treating respiratory track infection and urinary track
infection.
Description
It is white to light brownish powder,odourless or bitter in taste.
Storage
Store at not exceeding 25ºC, Protect in tight containers.
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Solubility
Freely soluble in methanol and ethanol, slightly soluble in ether, very slightly
soluble in water and practically insoluble in chloroform.
Identification
i) Melting point
Standard value Observed average value*
111 ºC - 113ºC 111ºC
*Average of six observations
ii) Infra red spectrum
Mechanism of action
It is a orally administered THIRD generation cephalosporin’s class of
antibacterial agent more active against enterobacteriaceae,streptococcus aureus and
β-lactamase producing H.influenzae,M.catarrhalis,N.gonorrhoeae & less active
against gram +ve cocci. It binds to one or more of the penicillin binding proteins
(PBPs) which inhibits the final transpeptidation step of peptidoglycon synthesis in
bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly
resulting in bacterial cell death.
Absorption
Decreased absorption in conditions of low gastric acidity. Bioavailability 50%.
Half life 2.2hrs.
Distribution
Cefpodoxime proxetil distributed in respiratory and GU tract in therapeutic
concentration.
Enters in breast milk in low concentrations.
Protein binding 20-30 %.
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Interactions
Antacids or H2 blockers may decrease the absorption of Cefpodoxime.
Probenecid inhibits renal secretion. Monitor renal function during administration.
Additive nephrotoxic effects with furosemide.
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2.2 REPORTED METHODS
REPORTED METHODS FOR AMBROXOL HYDROCHLORIDE
1. Umadevi. B et al., (2011), reported “Development and Validation of UV
Spectrophotometric determination of Doxofylline and Ambroxol HCl in bulk
and combined tablet formulation”. The method employs simultaneous equation
using the absorbance at 274 and 244.5nm for Doxofylline and Ambroxol. For
absorbance correction method 274nm for Doxofylline and 308nm for Ambroxol were
Doxofylline shows nil absorbance.
2. Nagavalli. D et al., (2011), reported “Validated HPLC method for the
Simultaneous estimation of Gemifloxacin Mesylate and Ambroxol HCl in bulk
and tablet dosage form”. The method has been developed with mobile phase
acetonitrile, methanol and trifluro acetic acid at the ratio of (25:20:55 % v/v) detected
in 248nm observed retention time were 2.69 mins and 3.43 mins.
3. Jain P.S.1 et al., (2010), reported “Stability-Indicating HPTLC determination of
Ambroxol Hydrochloride in bulk drug and pharmaceutical dosage form”. The
method employed HPTLC aluminium plates precoated with silica gel 60F-254 as the
stationary phase. The solvent system consisted of methanol-triethylamine (4:6, v/v).
Densitometric analysis of Ambroxol hydrochloride was carried out in the absorbance
mode at 254 nm.
4. Prathap. B et al., (2010), reported “Simultaneous determination of Gatifloxacin
and Ambroxol Hydrochloride from tablet dosage form using RP-HPLC”. A
Reversed-Phase High Performance Liquid Chromatography (HPLC) method was
developed, validated, and used for the quantitative determination of Gatifloxacin
(GA) and Ambroxol Hydrochloride (AM), from its tablet dosage form.
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Chromatographic separation was performed on a Thermo Hypersil Keystone ODS
C18 column (250 mm × 4.6 mm, 5 μm), with a mobile phase comprising of a mixture
of phosphate buffer and acetonitrile (60:40, v/v), and pH adjusted to 3 with ortho
phosphoric acid, at a flow rate of 1 mL/min, with detection at 250 nm.
5. Deshpande et al., (2010), reported “Application of HPLC and HPTLC for the
Simultaneous determination of Cefixime Trihydrate and Ambroxol HCl in
pharmaceutical dosage form”. The HPTLC method involves desitometric
measurements at 254nm, the separation was on aluminium sheets of Silica gel 60 F
254 using acetonitrile : methanol : triethylamine (8.2:1:0.8,v/v/v) as mobile phase.
The HPLC method was carried on column C18 at ambient temperature using   mobile
phase acetonitrile: methanol (50:50, v/v) UV detection at 254nm.
6. Senthil Raja. M et al., (2010), reported “RP-HPLC method Development and
validation for the simultaneous estimation of Azithromycin and Ambroxol
Hydrochloride in Tablets”. The separation was carried out using a mobile phase
consisting of acetonitrile and mono basic potassium phosphate buffer of pH 8.5 in the
ratio of 65:35 v/v. The column used was C18 phenomenex Gemini 5m, 250cm x
4.6mm id with flow rate of 2ml/min using PDA detection at 220nm.
7. Makarand Avhad et al., (2009), reported “Develoment and validation of
Simultaneous UV- spectrophotometric method for the determination of
Levofloxacin and Ambroxol in tablets”. The method involves Q-absorbance
equation at 219nm isoabsorptive point and at 287nm using distilled water as a solvent.
8. Krishna Veni Nagappan et al., (2008), reported “A RP-HPLC Method for
Simultaneous Estimation of Ambroxol Hydrochloride and Loratidine in
Pharmaceutical Formulation”. The method was carried out on a Phenomenex
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Gemini C18 (25 cm x 4.6 mm i.d., 5 μ) column with a mobile phase consisting of
acetonitrile: 50mM Ammonium Acetate (50:50 v/v) at a flow rate of 1.0 mL/min.
Detection was carried out at 255 nm.
9. Neela M Bhatia et al., (2008), reported “RP-HPLC and Spectrophotometric
estimation of Ambroxol and Cetirizine Hydrochloride in combined dosage
form”. The chromatographic methods were standardized using a HIQ SIL-C 18
column (250×4.6 mm i.d., 10 µm particle size) with UV detection at 229 nm and
mobile phase consisting of methanol-acetonitrile-water (40:40:20, v/v/v).
10. Lakshmana prabhu. S et al., (2008), reported “Simultaneous UV
spectrophotometric estimation of Ambroxol HCl and levoceterizine
Dihydrochloride”. The method involved solving simultaneous equations based on
measurement of absorbance at two wavelengths 242nm and 231nm.
11. Pai PNS et al., (2006), reported “Determination of Ambroxol Hydrochloride
using Dithiocarbamic acid Colorimetric method”. A new simple, colorimetric
method was developed on the basis of a chemical reaction of amine group in
Ambroxol Hydrochloride with carbon disulphide to form Dithiocarbamic acid, which
on further reaction with cupric chloride forms a colored copper chelate. The
yellowish-orange chromophore has absorption maxima of 448 nm.
12. Meiling Qi et al., (2004), reported “Liquid chromatography method for
determination of Roxithromycin and Ambroxol Hydrochloride in a new tablet
formulation”. This chromatographic method was achieved on a Diamonsil TM C18
column. The mobile phase consisting of a mixture of acetonitrile, methanol and 0.5%
ammonium acetate (39:11:50v/v) Detection was carried out at 220nm.
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13. Dincer et al., (2003), reported “Quantitative determination of Ambroxol in
tablets by Derivative UV spectrophotometric method and HPLC”. Determination
of Ambroxol was conducted by using First-order derivative UV-spectrophotometric
method at 255nm.This chromatographic method was achieved on C18 column with a
mixture of aqueous phosphate (0.01 m), acetonitrile and glacial acetic acid
(59:40:1, v/v/v).
14. Kuchekar. B.S et al., (2003) reported “Spectrophotometric estimation of
Ambroxol HCl in tablets”. The colorimetric method was carried out by two
different reagents by using Sodium nitrite, Napthyl ethylene diamine produced
pinkish red chromogen at 500nm and by using Ferric nitrate and Nitric acid produced
yellowish orange chromogen at 400nm.
15. Francisco G et al., (2001), reported “Determination of Ambroxol
Hydrochloride by HPLC”. Reverse phase liquid chromatography was employed,
using methanol-0.01 M di ammonium phosphate buffer, pH=6, (70:30, v/v) and a
detector wavelength of 247 nm.
16. Narayana reddy. M et al., (1998), reported “Spectrophotometric determination
of Ambroxol”. The method developed by using reagents 3-methyl-2-benzolinone
hydrazone (MBTH) and Ferric chloride (FeCl3) and Potassium ferricyanide
[K3Fe (CN) 6].
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REPORTED METHODS FOR CEFPODOXIME PROXETIL
17. Shah. M. N et al., (2012), reported “Development and Validation of
Spectophotometric method for Simultaneous determination of Cefpodoxime
proxetil and Ofloxacin in tablets”. The method involved solving Simultaneous
equations based on measurement of absorbance at two wavelengths 236 and 299nm in
methanol.
18. Patel Sanket A et al., (2011), reported “Simultaneous Spectrophotometric
determination of Cefpodoxime proxetil and Ofloxacin in tablets”. This method
involves the ratio of absorbances at two selected wavelength one isoabsorptive point
at 273.2nm and the other 297nm for Cefpodoxime proxetil and Ofloxacin in
methanol.
19. Patel Sanket A et al., (2011), reported “Dual wavelength spectrophotometric
method for Simultaneous estimation of Ofloxacin and Cefpodoxime proxetil in
tablet dosage form”. This method was based on determination of Ofloxacin at the
absorbance difference between 224nm and 247.4nm, for Cefpodoxime proxetil the
absorbance difference is between 278.2nm and 320nm.
20. Patel Sanket A et al., (2011), reported “Development and Validation of First
order Derivative spectrophotometric method for simultaneous estimation of
Ofloxacin and Cefpodoxime proxetil in tablet dosage form”. This method involves
the simultaneous determination of Ofloxacin and Cefpodoxime proxetil by derivative
spectrophotometric method at zero crossing points 236.4nm for Cefpodoxime proxetil
and 208.8nm for Ofloxacin.
21. Sunil singh et al., (2010), reported “Spectrophotometric and RP-HPLC
methods for simultaneous determination of Cefpodoxime proxetil and Clavunate
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Potassium in combined tablet dosage form”. This method involves the
Simultaneous equation estimation 0f Cefpodoxime proxetil and Clavunate potassium
at 235nm and 270nm in methanol.
22. Malathi. S et al., (2009), reported “Simultaneous Rp-HPLC estimation of
Cefpodoxime proxetil and clavunic acid in tablets”. This method was carried out
on a Zorbax Eclipse XDB 5µ C18 (150 x 4.6mm) column with mobile phase
consisting of acetonitrile:50 mm potassium dihydrogen phosphate buffer (pH 3.0) at
the ratio of 70:30 v/v at detection 228nm.
23. Gandhi.S.V et al., (2009), reported “Simultaneous spectrophotometric
determination of Cefpodoxime proxetil and Potassium clavunate”. This method
employs absorbance correction method at the wavelength 288nm for CEF were
Potassium clavunate shows nil absorbance its absorbance was observed at 218nm.
And for derivative spectroscopy 235.6nm and 300.2nm was selected for Potassium
clavunate and CEF respectively.
24. Darji. S. H et al., (2007), reported “Development and Validation of HPTLC
method for the estimation of Cefpodoxime proxetil”. The proposed method was
validated by using mobile phase a mixture of Chloroform:Methanol:Toluene
(4:2:4 v/v/v). The detection spot was carried out at 289nm.
25. Shah. P. B et al., (2006), reported “RP-HPLC for the determination of
Cefpodoxime proxetil”. In this method the drug was eluted from a 5mcm reverse
phase column at 25ºC temperature with mobile phase consisting of 50mm Phosphate
buffer (pH 3.0 ± 0.1) adjusted with 10% phosphoric acid and methanol (80:20,v/v)
with detection at 228nm.
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26. Srinivasa rao. Y et al., (2003), reported “Spectrophotometric method for the
estimation of Cefpodoxime proxetil”. This method is based on the reaction of the
drug with Ferric chloride and Potassium ferricyanide, which forms a green chromogen
exhibiting maximum absorption at 780 nm.
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3. AIM AND PLAN OF WORK
The combined dosage form selected for the present study containing
Cefpodoxime proxetil and Ambroxol HCl in tablets, this combination recently entered
into the market. Cefpodoxime proxetil and Ambroxol HCl in combined dosage form
used in treatment of respiratory tract infections.
In the view of the literature cited for the quantification of Cefpodoxime
proxetil and Ambroxol HCl, it was found that the method for estimation of
Cefpodoxime proxetil and Ambroxol HCl individually and in combination with other
drugs were available. No method available for the simultaneous estimation of
Cefpodoxime proxetil and Ambroxol HCl in combined dosage form.
Hence in the present work, the aim is to develop a simple, precise and accurate
methods for the estimation of Cefpodoxime proxetil and Ambroxol HCl in bulk and in
combined pharmaceutical dosage form and to validate the developed methods by UV
spectrophotometry and RP – HPLC.
Validation of Developed method
The developed method should be validated as per ICH guidelines. The
parameters used to validate the developed method are; Accuracy, Precision, Linearity,
Range, Repeatability, Reproducibility, Limit of Detection, Limit of Quantification,
Ruggedness. The system suitability parameters like Capacity factor, Asymmetry
factor, Tailing factor, Theoretical plates, HETP and Resolution should be calculated
for RP – HPLC chromatograms and compared with standard values.
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For UV method:
1) Find the solubility of drugs in various solvents
2) To determine maximum absorbance and selection of wavelengths for
detection.
3) Determining the standard absorbance for all selected wavelengths for each
drug.
4) Development of simple, precise, accurate and sensitive
 Simultaneous equation method
 Area under the curve method
 Derivative spectroscopic method , in the specified range
5)Validation of developed methods as per ICH guidelines.
For RP-HPLC method:
1) Selection of suitable mobile phase for two drugs with proper resolution and
short duration of time
2) Development of chromatogram with various concentration for each drug to
determine range of concentrations
3) Relating area of chromatogram with respect to concentration for individual
drugs
4) Determination of percentage purity of physical mixture  and in formulation
5) Validation of the developed method
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4. MATERIALS AND METHODS
4.1 MATERIALS
4.1.1 Drugs
Cefpodoxime proxetil and Ambroxol HCl were generously gifted by Madras
pharmaceuticals ltd Chennai and the formulation Finecef- AM TAB from a local
pharmacy.
4.1.2 Reagents and Chemicals
All the chemicals used were of analytical grade and HPLC grade procured
from Qualigens, India Ltd. The chemicals used for the study were
Methanol (analytical grade)
Acetonitrile (HPLC Grade)
Methanol (HPLC Grade)
Water (HPLC Grade)
Ortho phosphoric acid (Analytical Grade)
4.1.3 Instruments specifications
a) Shimadzu AUX- 200 digital balance
b) Shimadzu 1700 double beam UV-visible spectrophotometer with a pair of
10 mm matched quartz cells
c) Thermo scientific spectra HPLC system (INERTSIL ODS-3V)
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d) Elico SL- 210 double beam UV-visible spectrophotometer with a pair of
matched quartz cells.
e) Remi centrifuge apparatus
f) Sonicator model 2120 MH
g) Cyberlab micropipette
h) Elico LI 120 pH meter
i) Melting point apparatus - Guna enterprises Chennai
4.1.4 Specifications (Terms) of instruments
a) Shimadzu AUX – 200 digital balance: (Shimadzu instruction manual)
Specifications
Weighing capacity 200 gms
Minimum display 0.1 mg
Standard deviation ≤ 0.1 mg
Operation temperature range 5 to 40° C
b) Shimadzu UV – Visible spectrophotometer: (Shimadzu instruction manual)
Model : Shimadzu, UV-1700, pharmaspec.; Cuvetts: 1 cm matched quartz cells
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Specifications
Light source
20 W halogen lamp, Deuterium lamp.
Light source position automatic adjustment.
Mechanism
Monochromator Aberration-correcting concave holographic grating
Detector Silicon Photodiode
Stray Light
0.04% or less (220 nm: NaI 10 g/l)
0.04% or less (340 nm: NaNo2 50 g/l)
Measurement
wavelength range 190~1100 nm
Spectral Band Width 1 nm or less (190 to 900 nm)
Wavelength Accuracy ± 0.5 nm automatic wavelength calibration
mechanism
Recording range
Absorbance : -3.99~3.99 Abs
Transmittance : -399~399%
Photometric Accuracy ± 0.004 Abs (at 1.0 Abs), ±0.002 Abs (at 0.5 Abs)
Operating
Temperature/Humidity
Temperature range : 15 to 35°C
Humidity range : 35 to 80% (15 to below 30° C)
35 to 70% (30 to 35° C)
c) Thermo scientific spectra High Performance Liquid Chromatography:
1. Column : Inertsil ods-3v (150mm X 4.6mm; 5 microns)
2. Column temperature : 30ºC
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3. Sample cooler temperature : 10ºC
4. Pump:  P 4000
5. Auto sampler  :  AS 3000
6. UV-Vis Detector  :  UV 2000
7. Vacuum Degasser  :  SCM 1000
8. System Controller  :  SN 4000
9.  Software  :  Chrom Quest 5.0
4.2 METHODS EMPLOYED
The methods employed for simultaneous estimation of Cefpodoxime proxetil and
Ambroxol HCl in combination are
4.2.1 UV Spectrophotometric method
a. Simultaneous equation method
b. Area under the curve  method
c. Derivative spectroscopic method
Selection of solvent
The solubility of drugs was determined in a variety of solvents as per Indian
pharmacopoeia standards. Solubility was carried out in polar to non polar solvents.
The common solvent was found to be methanol for the analysis of Cefpodoxime
proxetil and Ambroxol HCl for proposed method.
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Preparation of standard stock solution
10 mg of Cefpodoxime proxetil and Ambroxol HCl raw material were
weighed and transferred into 10 ml volumetric flasks separately and dissolved in
methanol and made up to the volume with methanol. These solutions were observed
to contain 1000 g mL-1.
Selection of wavelengths for estimation and stability studies
The selection of wavelengths for the estimation of Cefpodoxime
proxetil and Ambroxol HCl a suitable diluted stock solution contain 10 g mL-1 of
each and the solutions were scanned between 200 – 400 nm by using methanol as
blank. From the overlaid spectra, by the observation of spectral characteristics of
Cefpodoxime proxetil and Ambroxol HCl were simultaneously estimated by
Simultaneous equation Method, Area under the curve method and Derivative
spectroscopic method. The wavelengths selected for simultaneous equation method
were 235nm and 248 nm also 235nm and 308nm. For Area under the curve method
was 229-238 nm and 291- 316nm. For Derivative Spectroscopic method, the zero
order spectrum was derivatised to first order spectrum in that 235 nm was selected for
the estimation of Ambroxol HCl, which is zero crossing for Cefpodoxime proxetil and
279nm was selected for the estimation of Cefpodoxime proxetil which is zero
crossing for Ambroxol HCl. The Stability was performed by measuring the
absorbance of same solution at different time intervals. It was observed that
Cefpodoxime proxetil was stable for 3 hours and Ambroxol HCl is stable for more
than 3 days at all the selected wavelengths.
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Preparation of calibration graph
The aliquots of stock solution of Cefpodoxime proxetil (1-5 ml of 50 g mL-1)
and Ambroxol HCl (1-5 ml of 30 g mL-1) were transferred into 10 ml volumetric
flasks and made up to the volume to get 5-30µg/ml and 3-18µg/ml concentrations
with methanol. The absorbance of different concentration solutions were measured at
235,248,308 nm in the normal spectrum and 229-238,291-316 nm in area under the
curve and in 10-60µg/ml and 6-36µg/ml concentrations of CEF & AMB was taken
279,235 nm in the first derivative spectrum for Cefpodoxime proxetil and Ambroxol
HCl. The calibration curve was plotted at their corresponding wavelengths. All two
drugs Cefpodoxime proxetil and Ambroxol HCl were linear with the concentration
range of 5-30 g /ml and 3-18 g/ml & 10-60µg/ml and 6-36µg/ml respectively at
their respective wavelengths and thus, it obeys the Beer’s law.
Quantification of formulation
Twenty tablets of formulation (Finecef-AM TAB) (containing Cefpodoxime
proxetil eq. to Cefpodoxime 100mg and 60 mg of Ambroxol HCl) were weighed
accurately. The average weight of tablets was found and powdered. The tablet powder
equivalent to 30 mg of Ambroxol was weighed and transferred into 50 ml volumetric
flask added a minimum quantity of  methanol to dissolve the substance by using ultra
sonication  for 15 minutes and made up to the volume with the same (1000 g mL-1).
The content filtered through Whatmann filter paper No. 41. From the clear solution,
further dilutions were made by diluting 1 ml to 10 ml volumetric flask, further dilute
1 ml to 10 ml to obtain 10 g/ ml of cefpodoxime which contains 6 g/ml of
Ambroxol HCl theoretically. The absorbance measurements were made 6 times for
the formulation at 235 nm, 248 nm, and 308nm, in simultaneous equation method. For
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area under the curve method the absorbance were 229-238 nm and 291-316 nm. And
for First order derivative method it was measured at 279nm, 239nm and the
absorbtivity values were calculated.  From the absorptivity values of Cefpodoxime
proxetil and Ambroxol HCl at 235 nm, 248 nm, 308 nm, 229-238 nm and 291-316 nm
and  235nm, 279nm  the amount of Cefpodoxime proxetil and  Ambroxol HCl were
determined by using Simultaneous equation method, Area under the curve  method
and  Derivative spectroscopic method. The procedure was repeated for three times for
each percentage.
Recovery studies
The recovery experiment was done by adding known concentrations of
Cefpodoxime proxetil and Ambroxol HCl raw material to the 50% preanalyzed
formulation. Standard Cefpodoxime proxetil and Ambroxol HCl in the range of 80 %,
100 % and 120% to the 50% preanalyzed formulation into a series of 10 ml
volumetric flasks and dissolved with methanol and made up to the mark with the
same. The contents were sonicated for 15 minutes. After sonication the solutions were
filtered through Whatmann filter paper No. 41. The absorbances of the resulting
solutions were measured at their selected wavelengths for determination of
Cefpodoxime proxetil and Ambroxol HCl respectively. The amount of each drug
recovered from the formulation was calculated for all the drugs by Simultaneous
equation method, Area under the curve method and Derivative spectroscopic method.
The procedure was repeated for three times for each percentage recovery.
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Validation of developed method
Linearity
A calibration curve was plotted between concentration and absorbance.
Cefpodoxime proxetil was linear with the concentration range of 5-30 g /ml at
235nm, 248nm, 308 nm, 229-238 nm, 291-316 nm and 10-60µg/ml at 279nm and
Ambroxol HCl showed the linearity in the range of 1-5 g /ml at 235nm, 248 nm,
308 nm, 229-238 nm, 291-316 nm and 6-36µg/ml at 235 nm by obeying Beer’s law.
Accuracy (Recovery studies)
Accuracy of the method was confirmed by recovery studies. To the 50%
pre-analyzed formulation, a known quantity of raw materials of Cefpodoxime proxetil
and Ambroxol HCl were added and the procedure was followed as per the analysis of
formulation. The amount of each drug recovered was calculated. This procedure was
repeated for three times for each concentration. The % RSD was calculated.
Precision
The repeatability of the method was confirmed by the analysis of formulation
was repeated for 6 times with the same concentration. The amount of each drug
present in the tablet formulation was calculated. The % RSD was calculated. The
intermediate precision of the method was confirmed by intraday and inter day analysis
i.e. the analysis of formulation was repeated three times in the same day and on three
successive days.  The amount of drugs was determined and % RSD also calculated.
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Ruggedness
Ruggedness of the method was confirmed by the analysis of formulation was
done by the different analysts. The amount and % RSD were calculated.
LOD and LOQ
The linearity study was carried out for six times. The LOD and LOQ were
calculated by using average value of slope and standard deviation of response
(Intercept).
4.2.2 HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD
Chromatographic method depends up on the nature of the sample, molecular
weight and solubility. The drug selected for the present study was polar compound;
hence it can be separated either by normal phase or reverse phase chromatography.
Reverse phase chromatographic technique was selected for initial separations with the
knowledge of properties of compound, C18 column was chosen as stationary phase
and various mixtures of water pH – 5 with ortho phosphoric acid, methanol and
acetonitrile were considered as mobile phase.
OPTIMIZATION OF MOBILE PHASE
MOBILE PHASE RATIO RETENTION TIMECEF AMB
AcN:MeOH:50mmPhos
buffer (pH 3) 50:20:30 2.72 Bp 1.73,1.84 Sg
AcN:MeOH:50mmPhos
buffer (pH 3) 40:20:40 4.28,4.54 Sg 1.95 Sp
AcN:MeOH:50mmPhos
buffer (pH 3) 30:20:50 9.46,10.7 Sg 2.57 Sp
AcN:MeOH:50mmPhos
buffer (pH 3) 40:10:50 6.66,7.26 Sg 1.98 Sp
AcN:MeOH:50mmPhos
buffer (pH 3) 20:10:70 15 Bp 7.79 Tg
AcN:MeOH:20mmAcet
buffer (pH 3) 30:50:20 2.24 Sp 3.18 Sp
AcN:MeOH:20mmAcet
buffer (pH 3) 40:20:40 2.32 Sp 3.20Sp
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AcN:MeOH:Water
(pH3) 40:40:20 2.17 Bp 1.50 Sp
AcN:MeOH:Water
(pH5) 40:40:20 2.22 Sp 3.82 Bp
AcN:MeOH:Water
(pH6) 40:40:20 1.97 Sp 3.01 Sp
AcN:MeOH:Water
(pH5) 25:50:25 2.56 Sp 5.51,6.03 Sg
AcN:MeOH:Water
(pH5) 25:55:20 2.25 Sp 4.51,4.84 Sg
AcN:MeOH:Water
(pH5) 30:40:25 2.47 Sp 5.29,5.61 Sg
AcN:MeOH:Water
(pH5) 35:45:20 2.01 Sp 3.55 Sp
AcN:MeOH:Water
(pH5) 30:50:20 3.45 Sp 4.30 Sp
Sg-splitting, Tg-tailing, Bp-Broad peak, Sp-Sharp peak.
AcN-Acetonitrile, MeOH-methanol, Phos-Phosphate, Acet-Acetate.
Selection of mobile phase and max
Different mixtures of mobile phase with different ratios were selected and
their chromatograms were recorded. From this Acetonitrile: Methanol: water pH – 5
with ortho phosphoric acid (30:50:20 % V/V/V) was selected as mobile phase, since
these two drugs were eluted with sharp peak and with better resolution.  Hence this
mobile phase was used to optimize the chromatographic conditions.
The detection wavelength was measured by scanning the 10 g/ml solution of
Cefpodoxime proxetil and Ambroxol HCl in mobile phase, in
UV- spectrophotometry, overlaid spectra and the wavelength of maximum absorption
was selected as 247 nm.
Optimized Chromatographic Conditions
The following parameters were used for RP-HPLC analysis of Cefpodoxime
proxetil and Ambroxol HCl.
Mode of operation - Isocratic
60
Stationary phase - C18 column (150mm × 4.6 mm I, d., 5m)
Mobile phase - Acetonitrile: Methanol: water pH – 5 with
ortho phosphoric acid (30:50:20% v/v/v)
Detection wavelength - 247 nm
Flow rate - 1 ml / min
Temperature - Ambient
Sample volume - 20 µl
Operating pressure - 121 kgf
Preparation of the Standard stock solution
Standard Cefpodoxime proxetil stock solution
Weighed accurately Cefpodoxime proxetil equivalent to cefpodoxime and
transferred into a 100 ml standard volumetric flask separately and dissolved with
minimum quantity of HPLC grade methanol and the volume was made up to the mark
with HPLC grade methanol to get the concentration of 1000 g mL-1 of Cefpodoxime
proxetil.
Standard Ambroxol HCl stock solution
Weighed accurately 60 mg of Ambroxol HCl and transferred into a 100 ml
standard volumetric flask separately and dissolved with minimum quantity of HPLC
grade methanol and the volume was made up to the mark with HPLC grade methanol
to get the concentration of 600 g mL-1 for Ambroxol HCl.
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Linearity and Calibration
From the standard solution, pipetted out 7-13 ml into a series of six 100 ml
volumetric flask and made up to the mark with mobile phase to obtain the
concentration range from 70-130 g mL-1 of Cefpodoxime proxetil and
42-78 g mL-1 of Ambroxol HCl solution were injected and chromatogram was
recorded. The calibration curve was plotted between concentration verses peak area.
Quantification of Cefpodoxime proxetil and Ambroxol HCl
Twenty Tablets containing Cefpodoxime proxetil eq. to Cefpodoxime 100 mg
and 60 mg of Ambroxol HCl were accurately weighed. Weighed the content of drug
equivalent to 48mg, 60 mg, 72mg of Ambroxol HCl was transferred to a 100 ml
volumetric flask and dissolved in HPLC grade methanol and sonicated for 15 minutes.
The final concentration was 600 g mL-1. The above solution was filtered through
whatmann filter paper and the clear solution was collected, 10 ml was pipetted into a
100 ml volumetric flask and made up to the mark with the mobile phase to produce 60
g mL-1 solutions. The peak area measurements were done by injecting each sample
three times and the amount of Cefpodoxime proxetil and Ambroxol HCl of lower,
middle and higher concentrations were calculated from their respective calibration
curve.
Recovery Studies
To ensure the reliability of the method, recovery studies were carried out by
mixing a known quantity of standard drug solution with the pre-analyzed sample
formulation and the content were mixed and made to the volume with mobile phase
and Pre-analyzed by the proposed method, the percentage recovery was calculated.
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Limit of Detection and Limit of Quantification
Preparation of calibration curve for the serial dilution of standard was repeated
for six times. The limit of detection and limit of quantification of each were calculated
by using the average value of slope and standard deviation of response (Intercept).
System Suitability Studies
The system suitability studies were carried out as specified in I.P. the
parameter like Column efficiency, Tailing factor, Asymmetric factor, and Theoretical
plate number and were calculated.
63
5. RESULTS AND DISCUSSION
Simultaneous estimation of multiple drug formulations have advantage that
the methods were less time consuming and usage of solvent is minimized. Three
simple, rapid, precise and accurate spectrophotometric and an isocratic RP – HPLC
methods were developed and validated for the estimation of Cefpodoxime proxetil
and Ambroxol HCl in mixture and in combined tablet dosage form. The drugs were
identified by IR Spectroscopy given in the figure 1 and 2. The methods employed for
the analysis of Cefpodoxime proxetil and Ambroxol HCl were
UV-spectrophotometric methods
Three simple, precise and accurate methods namely
Simultaneous equation method
Area under the curve method
Derivative spectroscopic method
RP- HPLC METHOD
5.1. SIMULTANEOUS EQUATION METHOD
The solubility of Cefpodoxime proxetil and Ambroxol HCl was determined as
per Indian Pharmacopoeia. The numeral polar and non – polar solvents were tried to
dissolve the drugs. From the solubility profile methanol was chosen as a common
solvent for the estimation of Cefpodoxime proxetil and Ambroxol HCl. The solubility
data is in Table-1 for Cefpodoxime proxetil and Ambroxol HCl.
The standard solutions of 10 g mL-1of Cefpodoxime proxetil  and  Ambroxol
HCl in methanol were prepared individually and the solutions were scanned in
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UV region in the wavelength range from 200 to 400 nm by using methanol as blank.
The individual and overlaid spectra of Cefpodoxime proxetil and Ambroxol
HCl were recorded as shown in Figure 3, 4 and 5. From the spectrum, 235 nm was
λmax of Cefpodoxime proxetil and 248 nm also 308nm was λmax of Ambroxol HCl,
these two wavelengths used for Simultaneous estimation of Cefpodoxime proxetil and
Ambroxol HCl respectively. Different aliquots of Cefpodoxime proxetil in Methanol
were prepared in the concentration range of 5– 30 g/ml. The absorbances of
solutions were measured at 235 nm, 248nm and 308 nm. The calibration curve was
plotted using concentration against absorbance. The calibration graph at 235nm,
248nm and 308 nm is shown in Figure-6, 7 and 8. Different aliquots of Ambroxol
HCl in Methanol were prepared in the concentration range of 3 – 18 g/ml. The
absorbances of these solutions were measured at 235nm, 248 nm and 308nm. The
calibration graphs were plotted and are shown in Figure 9, 10 and 11. The preparation
of calibration curve was repeated for six times for each drug at their selective
wavelengths. The optical parameters like, Sandell’s sensitivity, Molar absorptivity,
correlation coefficient, slope, intercept, LOD, LOQ and Standard error were
calculated. The correlation coefficient for the two drugs was found to be above 0.999.
This indicates that all the drugs obey Beer’s law in the selected concentration range.
Hence the concentrations were found to be linear. The optical characteristics of two
drugs at their selective wavelengths are shown in Table-2 for Cefpodoxime proxetil
and Table-3 for Ambroxol HCl.
FINECEF- AM TAB containing Cefpodoxime proxetil eq. to Cefpodoxime
100mg and 60mg of Ambroxol HCl was selected for analysis. The nominal
concentration of Cefpodoxime proxetil from linearity (10 g/ml) was prepared and
also contains (6 g/ml) Ambroxol HCl; the absorbances of the solution were
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measured at their respective wavelengths. The percentage label claim present in tablet
formulation was given in Table-4, 5 for Cefpodoxime proxetil and Ambroxol HCl,
respectively.
The amount present in tablet formulation was in good concord with the
label claim and the % RSD values were found to be 0.089032 and 0.160045 at
235,248nm  and 0.080327 and 0.302204 at 235,308nm for Cefpodoxime proxetil  and
Ambroxol HCl, respectively. The low % RSD values indicate that the method has
good precision. The results of analysis are shown in Table-4, 5.
Further the precision of the method was confirmed by Intraday and Inter day
analysis. The analysis of formulation was carried out for three times in the same day
and one time in the three consecutive days. The % RSD value of intraday and inter
day analysis were found to be and 0.020845 and 0.582865 at 235,248nm and
0.017043 and 0.948845 at 235,308nm for Cefpodoxime proxetil, 0.07554 and
0.398516 at 235, 248 nm and 0.091992 and 0.168291 at 235,308nm for Ambroxol
HCl. The results of analysis are shown in Table-6, 7. The results showed that the
precision of the method was confirmed.
The developed method was validated for Ruggedness. It refers to the
specific of one lab to multiple days which may include multiple analysts, multiple
instruments and different sources of reagents and so on. In the present work it was
confirmed by different analysts. The % RSD value by analyst 1 and analyst 2 were
found to be  0.089032, 0.070458 at 235,248nm and 0.080327, 0.080456 at
235,308nm  for  Cefpodoxime proxetil  and 0.160045, 0.191136 at 235,248nm and
0.302204, 0.302295 at 235,308nm  for Ambroxol HCl respectively. The low % RSD
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values indicate that the developed method was more rugged. The results are shown in
Table 8, 9.
The accuracy of the method was performed by recovery studies. To the
preanalysed formulation, a known quantity of Cefpodoxime proxetil and Ambroxol
HCl raw material solutions were added at different levels. The absorbance of the
solutions was measured and the percentage recovery was calculated. The percentage
recovery was found to be in the range of 100.17 – 100.44 % at 235,248nm and
98.91- 99.62 % at 235, 308nm  for Cefpodoxime proxetil  and  98.97 – 99.70% at
235, 248nm and 100.26-100.49 % at 235, 308nm  for Ambroxol HCl. The low %
RSD value for the two drugs indicates that this method is very accurate. The recovery
data is shown in Table- 10, 11.
5.2. AREA UNDER THE CURVE METHOD
A simple, accurate, rapid and precise Area under the curve method was
developed and validated. Methanol was chosen as a common solvent for estimation of
Ambroxol HCl and Cefpodoxime proxetil.
From the working standard solutions 6 g mL-1 of Ambroxol HCl and
10 g mL-1 Cefpodoxime proxetil in methanol was prepared separately and the
solutions were scanned in UV region in the wavelength range from 200 to 400 nm by
using Methanol as blank and the area was fixed between two nm. It is shown in the
fig-12 and 13 respectively. From the individual spectra area absorbance was
calculated between two nm were the absorbances was nearly same was selected for
the estimation of Cefpodoxime proxetil and Ambroxol HCl simultaneously at
229-238nm, 291-316nm.
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Different aliquots of Ambroxol HCl and Cefpodoxime proxetil were diluted to
the concentration range separately in distilled water. The area of each solution curves
were measured between 229-238nm and 291- 316 nm. The calibration curve was
plotted using absorbance against concentration. The calibration graph at 229-238 nm
and 291-316 nm for Cefpodoxime proxetil is shown in Figures 14- 15. The calibration
graph at 229-238 nm and 291-316nm for Ambroxol HCl are shown figure-16, 17
respectively. The preparation of calibration curve was repeated for six times for each
drug at their selective wavelengths. The optical parameters like, sandell’s sensitivity,
molar absorptivity, correlation coefficient, slope, intercept, LOD, LOQ and standard
error were calculated. The correlation coefficient for both the drugs was found to be
above 0.999. This indicates that both the drugs obey Beer’s law in the selected
concentration range. Hence the concentrations were found to be linear. The optical
characteristics of both drugs at selected wavelengths are shown in Table-12 for
Cefpodoxime proxetil and Table-13 for Ambroxol HCl
FINECEF-AM TAB each containing Cefpodoxime proxetil eq. to
Cefpodoxime proxetil 100mg and 60mg of Ambroxol HCl was selected for analysis.
The nominal concentration of Cefpodoxime proxetil from linearity 10 g mL-1, when
prepared contains 6 g mL-1 of Ambroxol HCl, the absorbance of the solutions were
measured at their selected wavelengths. The amount present in tablet formulation was
in good concord with the label claim and the % RSD values were found to be
0.071185 and 0.151326 for Cefpodoxime proxetil and Ambroxol HCl respectively.
The low % RSD values indicate that the method has good precision. The result of the
formulation estimations was shown in Table-14.
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Further the precision of the method was confirmed by intraday and inter day studies.
The analysis of formulation was carried out for three times in the same day and one
time in the three consecutive days. The % RSD value of intraday and inter day
analysis were found to be 0.017369 and 0.030643 for Cefpodoxime proxetil,
0.034482 and 0.066243 for Ambroxol HCl. The results of analysis are shown in
Table-15. The results showed that the precision of the method was high.
The developed method was validated for ruggedness. In the present work it
was confirmed by different analysts. The % RSD value by analyst 1 and 2 were found
to be 0.071185 and 0.060199 for Cefpodoxime proxetil, 0.151326 and 0.103921 for
Ambroxol HCl. The low % RSD values indicate that the developed method was more
rugged. The results are shown in Table-16.
The accuracy of the method was confirmed by recovery studies. To the
pre-analyzed formulation, a known quantity of mixture of Ambroxol HCl and
Cefpodoxime proxetil raw material solutions were added at different levels. The
absorbances of the solutions were measured at selected wavelengths and the
percentage recovery was calculated. The percentage recovery was found to be
100.4674 % for Cefpodoxime proxetil and 99.3191 % for Ambroxol HCl. The % RSD
values were found to be 0.029872 and 0.269187 for Cefpodoxime proxetil and
Ambroxol HCl respectively. The low % RSD value for both drugs indicates that this
method is very accurate. The recovery data is shown in Table-17.
5.3 DERIVATIVE SPECTROSCOPIC METHOD
A simple, accurate, rapid and precise first order derivative method was
developed and validated. The common solvent used for estimation of Cefpodoxime
proxetil and Ambroxol HCl was chosen is Methanol.
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The sample solutions of 10 g mL-1 of Cefpodoxime proxetil  and  Ambroxol
HCl in methanol were prepared individually and the solutions were scanned in
UV region in the wavelength range from 200 to 400 nm by using methanol as
blank. The zero order spectrum were derivatised into first order derivative spectrum
individually as shown in the figure- 18, 19. The overlaid first order derivative
spectrum of Cefpodoxime proxetil and Ambroxol HCl was recorded as shown in
Figure-20. From the spectrum, 235 nm and 279 nm were selected for the estimation of
Cefpodoxime proxetil and Ambroxol HCl respectively without any interference. At
235 measured nm, Cefpodoxime proxetil was zero. At 279 nm, Ambroxol HCl has
zero absorbance value. Hence these two wavelengths were selected for the analysis of
Cefpodoxime proxetil and Ambroxol HCl, respectively. Different aliquots of
Cefpodoxime proxetil and Ambroxol HCl were prepared in the concentration range of
10 - 60 g/ml and 6 – 36 g/ml, respectively. The absorbances of these solutions
were measured at 235 nm and 279 nm in the first order derivative spectrum for
Cefpodoxime proxetil and Ambroxol HCl, respectively. The plotted graphs are
shown in Figure 21 and 22 for Cefpodoxime proxetil and Ambroxol HCl,
respectively. The preparation of calibration curve was repeated for six times for
each drug at their selective wavelength. The calibration curve was plotted using
concentration against absorbance. The optical parameters like, Sandell’s sensitivity,
Molar absorptivity, Correlation coefficient, Slope, Intercept, LOD, LOQ and Standard
error were calculated for the two drugs. The correlation coefficient for the two drugs
was found to be above 0.999. This indicates that the two drugs obey Beer’s law in the
selected concentration range. Hence the concentrations were found to be linear. The
results are shown in Table-18.
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FINECEF- AM TAB containing Cefpodoxime proxetil eq. to Cefpodoxime
proxetil 100mg and 60mg of Ambroxol HCl was selected for analysis. The solution
contains 10 g mL-1 of Cefpodoxime proxetil was prepared (nominal concentration in
the calibration curve of Cefpodoxime proxetil), which also contains 6 g mL-1 of
Ambroxol HCl, the absorbance of these solutions were measured at 279 nm and 235
nm. The amount of six test solutions was determined. The amount present in tablet
formulation was in good concord with the label claim and the % RSD values were
found to be 0.406486 and 0.595885 for Cefpodoxime proxetil and Ambroxol HCl,
respectively. The results of analysis are shown in Table-19. The low % RSD values
indicate that the method has good precision.
Further the precision of the method was confirmed by Intraday and Inter day
analysis. The analysis of formulation was carried out for three times in the same day
and one time in the three consecutive days. The % RSD value of Intraday and Inter
day analysis are 0.368593 and 0.198141 for Cefpodoxime proxetil, 0.635013 and
0.664226 for Ambroxol HCl, respectively. The results of analysis are shown in
Table-20. Hence the precision was confirmed. The results showed that the precision
of the method was further confirmed.
The developed method was validated for Ruggedness. It refers to the specific
of one lab to multiple days which may include multiple analysts, multiple instruments
and different sources of reagents and so on. In the present work it was confirmed
by different analysts. The % RSD value by analyst 1 and analyst 2 were found to be
0.406486 and 0.230238 for Cefpodoxime proxetil and 0.595885 and 0.893351 for
Ambroxol HCl, respectively. The low % RSD values indicate that the developed
method was more rugged. The results are shown in Table-21.
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The accuracy of the method was performed by recovery studies. To the
pre-analyzed formulation, a known quantity of Cefpodoxime proxetil and Ambroxol
HCl raw material solutions were added at different levels. The absorbance of the
solutions was measured and the percentage recovery was calculated. The percentage
recovery was found to be in the range of 100.86-101.18 % for Cefpodoxime proxetil,
and 99.84-100.29 % for Ambroxol HCl. The low % RSD value for the two drugs
indicates that this method is very accurate. The recovery data is shown in Table 22.
5.4 RP-HPLC METHOD
An involvement was made in this project to device, a simple, accurate, less
expensive and sensitive RP-HPLC method of estimation of Cefpodoxime proxetil and
Ambroxol HCl in solid dosage form. Since the drug is polar reverse phase high
performance liquid chromatography was selected.
Selection of Mobile Phase
Acetonitrile was preferred because of its lower viscosity and high UV
transparency. Methanol was selected due to its inexpensiveness and also it is a good
diluent for this drug. Acetonitrile: Methanol: Water in different ratio was tried and
elution of was founded as splitted. Hence choice of orthophosphoric acid was
incorporated to adjust pH. According to the pKa values of both the drugs pH-3 and
pH-5 were selected. An attempt was made in phosphate buffer instead of water in
different ratio, this also gave splitted peaks. Hence Acetonitrile: Methanol: Water
pH-5 in the ratio 30:50:20 v/v/v this gave sharper peaks and it was selected as mobile
phase.
72
The detection wavelength was measured by scanning the solution of
Cefpodoxime proxetil and Ambroxol HCl in mobile phase. In
UV-spectrophotometry, spectra was overlined and wavelength of maximum
absorption was selected as 247 nm.
The limit of detection and the limit of quantification were determined by using
slope and standard deviation and it was calculated. The system suitability parameters
such as Theoretical plate, Tailing factor, Asymmetric factor and Resolution were
calculated and shown in Table-23, the parameters were found to be satisfactory as per
ICH guidelines.
With the optimized chromatographic conditions, stock solutions of
Cefpodoxime proxetil and Ambroxol HCl were prepared in HPLC methanol and the
final dilution with mobile phase and prepared the mixture in the concentration range
70-130 g mL-1 of Cefpodoxime proxetil and 42-78 g mL-1 of Ambroxol HCl, 20 µl
of each solution was injected and records the chromatogram at 247 nm.
The chromatogram optimized given in Figure-26, the calibration curve
was plotted using concentration against peak area from the fig-27 to fig-33. The
procedure was repeated for three times. The correlation coefficient was found to be
above 0.9997 and 0.9999 Cefpodoxime proxetil and Ambroxol HCl. The calibration
graph of Cefpodoxime proxetil and Ambroxol HCl are shown in Fig-34 and Fig-35
respectively.  The optical characteristics of Cefpodoxime proxetil and Ambroxol HCl
shown in Table-24.
The Tablet dosage form FINECEF-AM TAB was selected for the analysis. The
ostensible concentration 80 g mL-1 , 100 g mL-1 , 120 g mL-1 of Cefpodoxime
proxetil in the mobile phase were prepared which contains 48 g mL-1 , 60 g mL-1 ,
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72 g mL-1 of Ambroxol HCl. 20 µl of each solution was injected and
chromatograms were recorded. The percentage purity was found to be 99.18%,
99.27%, 99.15% of low, middle, and high level dilutions for Cefpodoxime proxetil
and 99.85%, 99.90%, 99.52% of low, middle, and high Ambroxol HCl respectively.
The precision of the method was confirmed by repeatability of
formulation for three times of each level dilutions and the chromatograms are shown
in Fig 36-44. The % RSD was found to be 0.2100, 0.1400 and 0.0903 of three levels
for Cefpodoxime proxetil and 0.0251, 0.01423, 0.1045 Ambroxol HCl respectively.
The data is shown in Table-25.
The accuracy of the method was performed by recovery studies to the pre
analysed formulation, a known quantity of Cefpodoxime proxetil and Ambroxol HCl
working standard solutions were added at different levels, injected the solutions. The
chromatograms were recorded as shown in the Fig 45-47. The percentage recovery
was found to in the range between 99.29-100.65% for Cefpodoxime proxetil and
98.99-100.38% for Ambroxol HCl. The percentage RSD was found to be 0.6885 and
0.7006 for Cefpodoxime proxetil and Ambroxol HCl respectively. The low
percentage of RSD values for recovery indicated that the method was found to be
accurate. The values given in the Table-26, the high percentage recovery revealed that
no interference was produced due to the excipients used in formulation. Therefore
developed method was found to be accurate.
All the above parameters with the ease of operations ensure that the projected
methods could be applied for the routine analysis of Cefpodoxime proxetil and
Ambroxol HCl pure form and in tablet dosage form.
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6. SUMMARY AND CONCLUSION
Cefpodoxime proxetil and Ambroxol HCl in combination used in treatment of
lower respiratory tract infections. A rapid, precise and accurate analytical method for
the simultaneous estimation of Cefpodoxime proxetil and Ambroxol HCl in
formulation (FINECEF- AM TAB) was developed.
FINECEF- AM TAB has been selected for study, which containing Cefpodoxime
proxetil eq. to Cefpodoxime 100 mg and 60 mg of Ambroxol HCl.
The methods proposed for this combination of drugs are
6.1 UV SPECTROSCOPIC METHOD:
UV spectrophotometric method for the estimation of Cefpodoxime proxetil and
Ambroxol HCl in combined dosage form by
(1) Simultaneous equation method
(2) Area under the curve method
(3) Derivative spectroscopic method
From the solubility data methanol is used as common solvent. Cefpodoxime
proxetil and Ambroxol HCl were prepared separately (10 g mL-1) and scanned in
UV region. From the overlaid spectra, by the observation of spectral characteristics of
Cefpodoxime proxetil and Ambroxol HCl, they were selected for Simultaneous
estimation, Area under the curve method and Derivative spectroscopic method. The
wavelengths selected for simultaneous estimation method were 235nm, 248 nm and
308nm, 229-238nm and 291-316 nm for the area under the curve method and 279 nm
and 235 nm for the Derivative spectroscopic method.
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1. Simultaneous Equation Method
The percentage label claim present in tablet formulation (FINECEF- AM TAB)
was found to be 99.87% and 101.09 % at 235,248nm and 101.64% and 99.58% at
235, 308nm for Cefpodoxime proxetil and Ambroxol HCl respectively. The
percentage recovery was found to be in the range of 100.17 – 100.44% and
98.97- 99.70% at 235, 248nm and 98.91-99.62% and 100.26-100.49% at 235,308nm
for Cefpodoxime proxetil and Ambroxol HCl.
In this accuracy, precision of two wavelengths of Ambroxol was compared. In
which 248nm is précised one than 308nm studied by its optical characteristics
obtained from linearity was good.
2. Area under the curve Method
The percentage label claim present in tablet formulation (FINECEF- AM TAB)
was found to be 99.73% and 100.48% for Cefpodoxime proxetil and Ambroxol HCl
respectively. The percentage recovery was found to be in the range of
100.44 – 100.50% and 99.03- 99.55% for Cefpodoxime proxetil and Ambroxol HCl.
3. Derivative Spectroscopic Method
The percentage label claim present in tablet formulation (FINECEF- AM TAB)
was found to be 99.94% and 101.77% for Cefpodoxime proxetil and Ambroxol HCl
respectively. The percentage recovery was found to be in the range of 100.86 –101.23
% and 99.84- 100.29% for Cefpodoxime proxetil and Ambroxol HCl.
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6.2 RP – HPLC METHOD:
RP-HPLC method has been developed for the estimation of both drugs in
bulk and in formulation. The proposed method gives reliable assay results with short
analysis time, using mobile phase Acetonitrile: Methanol: water pH-5 with
orthophosphoric  acid in the ratio of 30:50:20 v/v/v. The percentage purity present in
tablet formulation (FINECEF-AM TAB) for 80%, 100%, 120% was found to be
99.18 %, 99.27% and 99.15% for Cefpodoxime proxetil and 99.85%, 99.90%, 99.52%
Ambroxol HCl repectively. The percentage recovery was found to be in the range of
99.29 –100.65 % and 98.99- 100.38 % for Cefpodoxime proxetil and Ambroxol HCl.
The contents of drug present in the formulation were found to be satisfactory and
system suitability parameters are in desired limit.
All the above methods do not suffer from any interference due to common
excipients. It indicates that methods were accurate. Therefore the proposed methods
could be successfully applied to estimate commercial pharmaceutical products
containing Cefpodoxime proxetil and Ambroxol HCl.
Thus the above study’s findings would be helpful to the analytical chemists to
apply the analytical methods for the routine analysis of the analyte in pharmaceutical
dosage forms.
Figure-1
IR SPECTRUM OF CEFPODOXIME PROXETIL
Figure-2
IR SPECTRUM OF AMBROXOL HYDROCHLORIDE
Figure-3
UV SPECTRUM OF CEFPODOXIME PROXETIL IN METHANOL
AT 235 nm (SIMULTANEOUS EQUATION METHOD)
Concentration: 10 g mL-1
Figure-4
UV SPECTRUM OF AMBROXOL HYDROCHLORIDE IN METHANOL
AT 248 nm, 308 nm (SIMULTANEOUS EQUATION METHOD)
Concentration: 10 g mL-1
Figure-5
OVERLAID SPECTRA OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHORIDE IN METHANOL
Figure-6
CALIBRATION CURVE OF CEFPODOXIME PROXETIL IN METHANOL
AT 235 nm (SIMULTANEOUS EQUATION METHOD)
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Figure-7
CALIBRATION CURVE OF CEFPODOXIME PROXETIL IN METHANOL
AT 248 nm (SIMULTANEOUS EQUATION METHOD)
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Figure-8
CALIBRATION CURVE OF CEFPODOXIME PROXETIL IN METHANOL
AT 308 nm (SIMULTANEOUS EQUATION METHOD)
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Figure-9
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE IN
METHANOL AT 235 nm
(SIMULTANEOUS EQUATION METHOD)
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Figure-10
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE IN
METHANOL AT 248 nm
(SIMULTANEOUS EQUATION METHOD)
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Figure-11
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE IN
METHANOL AT 308 nm
(SIMULTANEOUS EQUATION METHOD)
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Figure-12
UV SPECTRUM OF CEFPODOXIME PROXETIL IN METHANOL
AT 229-238 nm (AREA UNDER THE CURVE METHOD)
Figure-13
UV SPECTRUM OF AMBROXOL HYDROCHLORIDE IN METHANOL
AT 291-316 nm (AREA UNDER THE CURVE METHOD)
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Figure-14
CALIBRATION CURVE OF CEFPODOXIME PROXETIL IN METHANOL
AT 229-238 nm (AREA UNDER THE CURVE METHOD)
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Figure-15
CALIBRATION CURVE OF CEFPODOXIME PROXETIL IN METHANOL
AT 291-316 nm (AREA UNDER THE CURVE METHOD)
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Figure-16
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE IN
METHANOL AT 229-238 nm (AREA UNDER THE CURVE METHOD)
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Figure-17
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE IN
METHANOL AT 291-316 nm (AREA UNDER THE CURVE METHOD)
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Figure-18
FIRST ORDER DERIVATIVE UV SPECTRUM OF CEFPODOXIME
PROXETIL IN METHANOL
(DERIVATIVE SPECTROSCOPIC METHOD)
Figure-19
FIRST ORDER DERIVATIVE UV SPECTRUM OF AMBROXOL
HYDROCHLORIDE IN METHANOL
(DERIVATIVE SPECTROSCOPIC METHOD)
Figure-20
OVERLAID FIRST ORDER DERIVATIVE SPECTRUM OF
CEFPODOXIME PROXETIL AND AMBROXOL HYDROCHORIDE IN
METHANOL
(DERIVATIVE SPECTRSCOPIC METHOD)
Figure-21
CALIBRATION CURVE OF CEFPODOXIME PROXETIL AT 279 nm
(DERIVATIVE SPECTROSCOPIC METHOD)
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Figure-22
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE AT 235 nm
(DERIVATIVE SPECTROSCOPIC METHOD)
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Figure-23
BLANK USING METHANOL
Figure 24
INITIAL SEPERATION CONDITIONS IN
ACETONITRILE: METHANOL: WATER-pH 5.0 with
ORTHOPHOSPHORIC ACID (30:50:20 % v/v)
Figure 25
INITIAL SEPERATION CONDITIONS IN
ACETONITRILE: METHANOL: WATER-pH 5.0 with
ORTHOPHOSPHORIC ACID (30:50:20 % v/v)
Figure-26
OPTIMIZED CHROMATOGRAM FOR CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
Figure-27
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(70, 42 µg/ ml)
Figure-28
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(80, 48 µg/ ml)
Figure-29
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(90, 54 µg/ ml)
Figure-30
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(100, 60 µg/ ml)
Figure-31
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(110, 66 µg/ ml)
Figure-32
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(120, 72 µg/ ml)
Figure-33
LINEARITY CHROMATOGRAM OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE
(130, 78 µg/ ml)
Figure-34
CALIBRATION CURVE OF CEFPODOXIME PROXETIL BY RP-HPLC
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Figure-35
CALIBRATION CURVE OF AMBROXOL HYDROCHLORIDE
BY RP-HPLC
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Figure-36
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR LOW LEVEL DILUTONS REPEATABILITY - 1
Figure-37
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR LOW LEVEL DILUTONS REPEATABILITY - 2
Figure-38
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR LOW LEVEL DILUTONS REPEATABILITY - 3
Figure-39
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR MID LEVEL DILUTONS REPEATABILITY – 1
Figure-40
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR MID LEVEL DILUTONS REPEATABILITY - 2
Figure-41
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR MID LEVEL DILUTONS REPEATABILITY – 3
Figure-42
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR HIGH LEVEL DILUTONS REPEATABILITY – 1
Figure-43
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR HIGH LEVEL DILUTONS REPEATABILITY - 2
Figure-44
CHROMATOGRAM FOR ANALYSIS OF FOMULATION FINECEF-AM
TAB FOR HIGH LEVEL DILUTONS REPEATABILITY - 3
Figure-45
CHROMATOGRAM FOR 110% RECOVERY OF FORMULATION
FINECEF-AM TAB
Figure-46
CHROMATOGRAM FOR 120% RECOVERY OF FORMULATION
FINECEF-AM TAB
Figure-47
CHROMATOGRAM FOR 130% RECOVERY OF FOMULATION
FINECEF-AM TAB
TABLES
TABLE-1
SOLUBILITY PROFILE OF CEFPODOXIME PROXETIL AND
AMBROXOL HCl IN POLAR AND NON POLAR SOLVENTS
S.NO SOLVENTS CEFPODOXIME PROXETIL
AMBROXOL
HYDROCHLORIDE
SOLUBILITY CATEGORY SOLUBILTY CATEGORY
1 Distilled water 10mg in 100ml Very slightlysoluble 10mg in 0.6ml
Sparingly
soluble
2 0.1 M Hydrochloric acid More than 100ml Practicallyinsoluble 10mg in 1ml
Sparingly
soluble
3 0.1 M Sodium Hydroxide More than 100ml Practicallyinsoluble 10mg in 100ml
Very slightly
soluble
4 Methanol 10mg in 0.1ml Freely soluble 10mg in 0.08ml Freely soluble
5 Ethanol 10mg in 0.1ml Freely soluble 10mg in 0.5ml Sparinglysoluble
6 Chloroform 10mg in 30ml Very slightlysoluble More than 100ml
Practically
insoluble
7 Di methyl formamide 10mg in 0.05ml Freely soluble 10mg in 0.06ml Freely soluble
8 Acetone 10mg in 0.05ml Freely soluble 10mg in 100ml Very slightlysoluble
9 Toluene 10mg in 50ml Very slightlysoluble More than 100ml
Practically
insoluble
10 Benzene 10mg in 50ml Very slightlysoluble More than 100ml
Practically
insoluble
11 n –Butanol 10mg in 0.3ml soluble 10mg in 8ml Slightlysoluble
12 Acetonitrile 10mg in 0.05ml Freely soluble 10mg in 100ml Very slightlysoluble
13 Hexane 10mg in 100ml Very slightlysoluble More than 100ml
Practically
insoluble
14 Di ethyl ether 10mg in 15ml Very slightlysoluble More than 100ml
Practically
insoluble
15 Isopropyl alcohol 10mg in 0.25ml Soluble 10mg in 5ml Slightlysoluble
16 Di chloro methane 10mg in 2ml Slightlysoluble More than 100ml
Practically
insoluble
17 Acetic acid 10mg in 0.1ml Freely soluble 10mg in 1ml Sparinglysoluble
18 Ethyl acetate 10mg in 0.15ml Soluble 10mg in 50ml Very slightlysoluble
19 Phosphate buffer pH 3 10mg in 100ml Very slightlysoluble 10mg in 1ml
Sparingly
soluble
20 Phosphate buffer pH 5 More than 100ml Practicallyinsoluble 10mg in 5ml
Slightly
soluble
21 Phosphate buffer pH 7 More than 100ml Practicallyinsoluble 10mg in 7ml
Slightly
soluble
22 Phosphate buffer pH 9 More than 100ml Practicallyinsoluble 10mg in 15ml
Very slightly
soluble
TABLE-2
OPTICAL CHARACTERSTICS OF CEFPODOXIME PROXETIL BY
SIMULTANEOUS EQUATION METHOD (235, 248, 308 nm)
PARAMETERS AT 235 nm* AT 248 nm* AT 308 nm*
Beers law limit
(µg mL-1) 5-30 (µg mL
-1) 5-30 (µg mL-1) 5-30 (µg mL-1)
Molar absorptivity
(Lmol-1cm-1) 18470.06786 16474.45469 51116.30408
Sandells sensitivity
( µg/cm2/0.001
A.U)
0.029948177 0.033581809 0.108832656
Correlation
coefficient (r) 0.99988 0.99989 0.99980
Regression
equation
( y= mx + c)
Y= (0.03342)x +
( -0.00297)
Y= (0.02980)x
+ (-0.00259)
Y= (0.00922)x +
(-0.000447)
Slope (m) 0.0334208 0.0298042 0.009220119
Intercept (c) -0.0029720 -0.0025952 -0.000447024
LOD (µg mL-1) 0.3230845 0.2335186 0.47452324
LOQ (µg mL-1) 0.979043 0.707632 1.437949215
Standard error 0.0056158 0.0047849 0.00212772
Absorptivity% 331.833 295.767 91.78546
*Mean of six observations
TABLE-3
OPTICAL CHARACTERSTICS OF AMBROXOL HYDROCHLORIDE BY
SIMULTANEOUS EQUATION METHOD (235, 248, 308 nm)
PARAMETERS AT 235 nm* AT 248 nm* AT 308 nm*
Beers law limit (µg
mL-1) 3-18 (µg mL-1) 3-18 (µg mL-1) 3-18 (µg mL-1)
Molar absorptivity
(Lmol-1cm-1) 7499.1844 12068.0928 3693.7898
Sandells sensitivity
( µg/cm2/0.001 A.U) 0.056537089 0.034806494 0.115827419
Correlation
coefficient (r) 0.99958 0.99973 0.99976
Regression equation
( y= mx + c)
Y= (0.01797)x +
(0.001149)
Y= (0.029111)x
+ (0.000035119)
Y= (0.087642)x
+ (0.00145)
Slope (m) 0.017972817 0.02911131 0.00876428
Intercept (c) 0.001149405 0.000035119 0.00145
LOD (µg mL-1) 0.537561213 0.45856963 0.354468818
LOQ (µg mL-1) 1.628973373 1.389604939 1.0741479
Standard error 0.003563439 0.004304659 0.00129398
Absorptivity
( % ) 182.2937 290.7699 90.24922
*Mean of six observations
TABLE-4
QUANTIFICATION OF TABLET FORMULATION (FINECEF-AM TAB)
BY SIMULTANEOUS EQUATION METHOD (235, 248 nm)
*Mean of six observations
Drug SampleNo.
Labeled
amount
(mg/tab)
Amount
found
(mg/tab)*
Percentage
Obtained*
(%)
Average
(%) S.D
%
R.S.D. S.E.
CEF
1
2
3
4
5
6
100
100
100
100
100
100
99.9368
99.7853
99.8000
99.7853
99.9368
99.9850
99.94
99.79
99.80
99.79
99.94
99.98
99.8733 0.08891 0.08903 0.0247
AMB
1
2
3
4
5
6
60
60
60
60
60
60
60.5909
60.8900
60.6109
60.8900
60.5909
60.5909
100.98
101.30
101.01
101.30
100.98
100.98
101.0917 0.16179 0.16004 0.0044
TABLE - 5
QUANTIFICATION OF TABLET FORMULATION (FINECEF-AM TAB)
BY SIMULTANEOUS EQUATION METHOD (235, 308 nm)
*Mean of six observations
Drug SampleNo.
Labeled
amount
(mg/tab)
Amount
found
(mg/tab)*
Percentage
Obtained*
(%)
Average
(%) S.D
%
R.S.D. S.E.
CEF
1
2
3
4
5
6
100
100
100
100
100
100
101.6847
101.6847
101.4847
101.6847
101.6847
101.6847
101.68
101.68
101.48
101.68
101.68
101.68
101.6467 0.0816 0.08032 0.0226
AMB
1
2
3
4
5
6
60
60
60
60
60
60
59.8140
59.6110
60.0609
59.6110
59.8140
59.6110
99.69
99.35
100.10
99.35
99.69
99.35
99.5883 0.3009 0.30220 0.0083
TABLE 6
INTRA DAY AND INTER DAY ANALYSIS OF FORMULATION BY
SIMULTANEOUS EQUATION METHOD (235,248 nm)
Drug SampleNo.
Labeled
amount
(mg/tab)
Percentage
obtained*
(%)
S.D % R.S.D.
Intra
day
Inter
day
Intra
day
Inter
Day
Intra
day
Inter
day
CEF
1
2
3
100
100
100
99.87
99.84
99.88
99.87
100.86
99.81
0.02081 0.0583 0.0208 0.5828
Mean 99.86 99.87
AMB
1
2
3
60
60
60
101.09
100.19
101.04
101.09
100.42
101.14
0.07630 0.4020 0.0755 0.3985
MEAN 101.10 100.69
*Mean of Three observations
TABLE 7
INTRA DAY AND INTER DAY ANALYSIS OF FORMULATION BY
SIMULTANEOUS EQUATION METHOD (235,308 nm)
Drug SampleNo.
Labeled
amount
(mg/tab)
Percentage
obtained*
(%)
S.D % R.S.D.
Intra
day
Inter
day
Intra
day
Inter
day
Intra
day
Inter
day
CEF
1
2
3
100
100
100
101.64
101.61
101.64
101.64
99.95
101.58
0.01732 0.9588 0.0170 0.9488
Mean 101.63 101.05
AMB
1
2
3
60
60
60
99.65
99.71
99.53
99.58
99.86
99.56
0.0916 0.1677 0.0919 0.1682
MEAN 99.63 99.66
*Mean of Three observations
TABLE-8
RUGGEDNESS STUDY BY SIMULTANEOUS EQUATION METHOD
(235, 248 nm)
Drug Condition
Average*
% Obtained S.D % R.S.D S.E.
CEF
Analyst 1
Analyst 2
Instrument 1
Instrument 2
99.8733
99.8550
99.8133
100.9233
0.088919
0.070356
0.088694
0.12242
0.089032
0.070458
0.088862
0.1213
0.0247
0.001954
0.002464
0.003401
AMB
Analyst 1
Analyst 2
Instrument 1
Instrument 2
101.0917
101.0533
101.2233
100.2833
0.161792
0.193149
0.405446
0.268527
0.160045
0.191136
0.400546
0.267768
0.004494
0.005365
0.011262
0.007459
TABLE-9
RUGGEDNESS STUDY BY SIMULTANEOUS EQUATION METHOD
(235, 308 nm)
Drug Condition
Average*
% Obtained S.D % R.S.D S.E.
CEF
Analyst 1
Analyst 2
Instrument 1
Instrument 2
101.6467
101.4833
101.5833
100.1700
0.08165
0.08165
0.10328
0.972091
0.080327
0.080456
0.10167
0.970441
0.002268
0.002268
0.002869
0.027003
AMB
Analyst 1
Analyst 2
Instrument 1
Instrument 2
99.5883
99.9366
99.5666
99.8933
0.30096
0.302104
0.382134
0.686809
0.302204
0.302295
0.383797
0.687542
0.00836
0.008392
0.010615
0.019078
TABLE 10
RECOVERY STUDY DATA OF 50% PRE ANALYSED FORMULATION
BY SIMULTANEOUS EQUATION METHOD (235, 248 nm)
Drug %
Amount
present*
(µg mL-1)
Amount
added*
(µg mL-1)
Amount
estimated*
(µg mL-1)
Amount
recovered*
(µg mL-1)
%
Recovery* S.D.
%
RSD S.E.
CEF
80
100
120
10
10
10
8
10
12
17.9862
19.9557
21.9775
7.9862
9.9557
11.9775
100.1721
100.4400
100.1866
0.1506 0.1502 0.0167
Mean 100.2662
AMB
80
100
120
6
6
6
4.8
6
7.2
10.8500
12.0313
13.2212
4.8500
6.0313
7.2212
98.9700
99.5023
99.7077
0.3807 0.3830 0.0423
Mean 99.3933
*Mean of Three observations
TABLE 11
RECOVERY STUDY DATA OF 50% PRE ANALYSED FORMULATION
BY SIMULTANEOUS EQUATION METHOD (235, 308 nm)
Drug %
Amount
present*
(µg mL-1)
Amount
added*
(µg mL-1)
Amount
estimated*
(µg mL-1)
Amount
recovered*
(µg mL-1)
%
Recovery* S.D.
%
RSD S.E.
CEF
80
100
120
10
10
10
8
10
12
18.0300
20.1100
22.0816
8.0300
10.1100
12.0816
99.6217
98.9120
99.3430
0.3575 0.3601 0.0397
Mean 99.2922
AMB
80
100
120
6
6
6
4.8
6
7.2
10.7710
11.9820
13.1633
4.7715
5.9823
7.1633
100.2610
100.4970
100.3773
0.1180 0.1175 0.0131
Mean 100.3784
*Mean of Three observations
TABLE-12
OPTICAL CHARACTERSTICS OF CEFPODOXIME PROXETIL BY
AREA UNDER THE CURVE METHOD
PARAMETERS AT 229-238 nm* AT 291-316 nm*
Beers law limit (µg mL-1) 5-30 (µg mL-1) 5-30 (µg mL-1)
Molar absorptivity
(Lmol-1cm-1) 164681.6166 156282.1181
Sandells sensitivity
(µg/cm2/0.001 A.U) 0.00339971 0.00356851
Correlation coefficient
(r) 0.99994 0.99993
Regression equation
( y= mx + c) Y= (0.2941)x +(0.011838) Y=(0.28034)x+(-0.000744)
Slope (m) 0.294150952 0.280345833
Intercept (c) 0.011838095 -0.000744643
LOD (µg mL-1) 0.184128613 0.347769322
LOQ (µg mL-1) 0.557965495 1.053846432
Standard error 0.032160772 0.037751137
Absorptivity
( % ) 2955.6756 2802.0336
*Mean of six observations
TABLE-13
OPTICAL CHARACTERSTICS OF AMBROXOL HYDROCHLORIDE BY
AREA UNDER THE CURVE METHOD
PARAMETERS AT 229-238 nm* AT 291-316 nm*
Beers law limit (µg mL-1) 3-18 (µg mL-1) 3-18 (µg mL-1)
Molar absorptivity
(Lmol-1cm-1) 85223.05364 86867.92156
Sandells sensitivity
(µg/cm2/0.001 A.U) 0.004854153 0.004773401
Correlation coefficient
(r) 0.99993 0.99989
Regression equation
( y= mx + c) Y= (0.20602)x +(0.000063) Y=(0.20957)x+(-0.000573)
Slope (m) 0.206027976 0.209579563
Intercept (c) 0.0000636905 -0.000573214
LOD (µg mL-1) 0.162339083 0.198614195
LOQ (µg mL-1) 0.491936622 0.6018611960
Standard error 0.015121428 0.019799428
Absorptivity
( % ) 2065.7850 2095.0691
*Mean of six observations
TABLE 14
QUANTIFICATION OF TABLET FORMULATION (FINECEF-AM TAB)
BY AREA UNDER THE CURVE METHOD
*Mean of six observations
Drug SampleNo.
Labeled
amount
(mg/tab)
Amount
found
(mg/tab)*
Percentage
Obtained*
(%)
Average
(%) S.D
%
R.S.D. S.E.
CEF
1
2
3
4
5
6
100
100
100
100
100
100
99.7050
99.6758
99.6758
99.8220
99.7050
99.8220
99.70
99.67
99.67
99.82
99.70
99.82
99.73 0.07099 0.07118 0.00197
AMB
1
2
3
4
5
6
60
60
60
60
60
60
60.3900
60.2900
60.2900
60.1900
60.3900
60.1900
100.65
100.48
100.48
100.31
100.65
100.31
100.48 0.15205 0.15132 0.00422
TABLE 15
INTRA DAY AND INTER DAY ANALYSIS OF FORMULATION BY
AREA UNDER THE CURVE METHOD
Drug
Sample
No.
Labeled
amount
(mg/tab)
Percentage
Obtained*
(%)
S.D % R.S.D.
Intra
day
Inter
day
Intra
day
Inter
day
Intra
day
Inter
day
CEF
1
2
3
100
100
100
99.73
99.73
99.70
99.73
99.69
99.67
0.0173 0.0305 0.0173 0.0306
MEAN 99.7200 99.6766
AMB
1
2
3
60
60
60
100.42
100.48
100.48
100.48
100.59
100.47
0.0346 0.0665 0.0344 0.0662
MEAN 100.460 100.513
*Mean of Three observations
TABLE 16
RUGGEDNESS STUDY BY AREA UNDER THE CURVE METHOD
Drug Condition
Average*
% Obtained S.D
%
R.S.D S.E.
CEF
Analyst 1
Analyst 2
99.7300
99.6700
0.070993
0.06000
0.071185
0.060199
0.001972
0.001667
AMB
Analyst 1
Analyst 2
100.4800
100.4483
0.152053
0.104387
0.151326
0.103921
0.004224
0.002900
TABLE 17
RECOVERY STUDY DATA OF 50% PRE ANALYSED FORMULATION
BY AREA UNDER THE CURVE METHOD
Drug %
Amount
present*
(µg mL-1)
Amount
added*
(µg mL-1)
Amount
estimated*
(µg mL-1)
Amount
recovered*
(µg mL-1)
%
Recovery* S.D.
%
R.S.D. S.E.
CEF
80
100
120
10
10
10
8
10
12
17.9600
19.9534
21.9462
7.9600
9.9534
11.9462
100.5008
100.4580
100.4433
0.0298 0.0297 0.0033
Mean 100.4674
AMB
80
100
120
6
6
6
4.8
6
7.2
10.8300
12.0266
13.2700
4.8300
6.0266
7.2700
99.3700
99.5574
99.0300
0.2673 0.2691 0.0297
Mean 99.3191
*Mean of Three observations
TABLE-18
OPTICAL CHARACTERSTICS OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE BY DERIVATIVE SPECTROSCOPIC
METHOD
PARAMETERS CEFPODOXIMEAT 279 nm*
AMBROXOL AT
235 nm*
Beers law limit (µg mL-1) 10-60 (µg mL-1) 6-36 (µg mL-1)
Molar absorptivity
(Lmol-1cm-1) 194.56606 242.87007861
Sandells sensitivity
( µg/cm2/0.001 A.U) 2.799078 1.788869362
Correlation coefficient (r) 0.99964 0.99949
Regression equation
( y= mx + c)
Y = (0.0003573)x +
(-0.0000839)
Y = (0.0005903)x +
(-0.0000458333)
Slope (m) 0.000357321 0.000590377
Intercept (c) -0.0000839286 -0.0000458333
LOD (µg mL-1) 0.046913171 1.357334448
LOQ (µg mL-1) 0.142161124 4.113134692
Standard error 0.00020266 0.000252753
Absorptivity
( % ) 3.534583292 5.865740833
*Mean of six observations
TABLE-19
QUANTIFICATION OF TABLET FORMULATION (FINEEF-AM TAB)
BY DERIVATIVE SPECTROSCOPIC METHOD
*Mean of six observations
Drug
Sample
No.
Labeled
amount
(mg/tab)
Amount
found
(mg/tab)*
Percentage
Obtained*
Average
(%) S.D
%
R.S.D. S.E.
CEF
1
2
3
4
5
6
100
100
100
100
100
100
100.1849
100.1849
99.4050
100.1849
99.4400
100.2740
100.18
100.18
99.40
100.18
99.44
100.27
99.9423 0.40625 0.40648 0.011285
AMB
1
2
3
4
5
6
60
60
60
60
60
60
60.7408
60.5900
60.9900
60.7408
60.9900
61.5900
101.16
102.50
101.65
101.16
101.65
102.5
101.77 0.60643 0.59588 0.01684
TABLE 20
INTRA DAY AND INTER DAY ANALYSIS OF FORMULATION BY
DERIVATIVE SPECTROSCOPIC METHOD
Drug SampleNo.
Labeled
amount
(mg/tab)
Percentage
obtained*
S.D % R.S.D.
Intra
day
Inter
day
Intra
day
Inter
day
Intra
day
Inter
day
CEF
1
2
3
100
100
100
99.89
99.20
99.33
99.81
99.49
99.45
0.3666 0.1973 0.3685 0.1981
MEAN 99.72 99.67
AMB
1
2
3
60
60
60
100.42
100.48
100.48
100.48
100.59
100.47
0.6365 0.6702 0.6350 0.6642
MEAN 100.46 100.51
*Mean of Three observations
TABLE 21
RUGGEDNESS STUDY BY DERIVATIVE SPECTROSCOPIC METHOD
Drug Condition
Average*
% Obtained S.D
%
R.S.D S.E.
CEF
Analyst 1
Analyst 2
99.9423
99.2966
0.406252
0.228619
0.406486
0.230238
0.011285
0.006351
AMB
Analyst 1
Analyst 2
101.7700
100.5800
0.606432
0.898532
0.595885
0.893351
0.016845
0.024959
TABLE-22
RECOVERY STUDY DATA OF 50% PRE ANALYSED FORMULATION
BY DERIVATIVE SPECTROSCOPIC METHOD
Drug %
Amount
present*
(µg mL-1)
Amount
added*
(µg mL-1)
Amount
estimated*
(µg mL-1)
Amount
recovered*
(µg mL-1)
%
Recovery* S.D.
%
R.S.D. S.E.
CEF
80
100
120
10
10
10
8
10
12
17.9060
19.9153
21.8539
7.9060
9.9153
11.8539
101.1861
100.8605
100.2330
0.2028 0.2006 0.0225
Mean 101.0932
AMB
80
100
120
6
6
6
4.8
6
7.2
10.8050
12.0099
13.1800
4.8050
6.0099
7.1800
99.9359
99.8400
100.2916
0.2379 0.2378 0.0264
Mean 100.0225
*Mean of Three observations
TABLE - 23
SYSTEM SUITABILITY PARAMETERS FOR THE OPTIMIZED
CHROMATOGRAM BY RP - HPLC
PARAMETERS CEFPODOXIMEPROXETIL
AMBROXOL
HYDROCHLORIDE
Tailing factor 1.14 1.16
Asymmetrical factor 1.44 1.49
Theoretical plates 4962 4637
Capacity factor 3.32125 4.385
Theoretical plate per unit
Length 330.8 309.133
Resolution Between CEF and AMB3.79
TABLE-24
OPTICAL CHARACTERISTICS OF CEFPODOXIME PROXETIL AND
AMBROXOL HYDROCHLORIDE BY RP - HPLC
PARAMETERS CEFPODOXIMEPROXETIL* AMBROXOL HCl*
Detection wavelength
(nm) 247 247
Beers law limit (μg mL-1) 70-130 (μg mL-1) 42-78 (μg mL-1)
Correlation coefficient (r) 0.9997 0.9999
Régression équation
(y=mx+c)
Y= (14303.1107)x+
(- 121339.6429)
Y=(14879.4881)x+
(-24882.5714)
Slope (m) 14303.1107 14879.4881
Intercept (c) -121339.6429 -24882.5714
LOD (μg mL-1) 0.000.37747 0.00054925
LOQ (μg mL-1) 0.001326507 0.001664394
Standard Error 0.60014693 1.093552806
*Mean of Three observations
TABLE -25
QUANTIFICATION OF TABLET FORMULATION (FINECEF-AM TAB)
BY RP-HPLC
Drug SampleNo.
Labeled
amount
(mg/tab)
Amount
found
(mg/tab)
Percentage
Obtained*
(%)
Average
(%) S.D.
%
R.S.D. S.E.
CEF
L   1
O   2
W   3
100
100
100
99.04
99.08
99.41
99.04
99.08
99.41
99.18 0.2100 0.2100 0.0225
M  1
I  2
D  3
100
100
100
99.22
99.17
99.43
99.22
99.17
99.43
99.27 0.1400 0.1400 0.0153
H  1
I  2
G  3
H
100
100
100
99.14
99.07
99.25
99.14
99.07
99.25
99.15 0.0903 0.0903 0.01800
AMB
L  1
O  2
W  3
60
60
60
59.91
59.92
59.89
99.85
99.87
99.82
99.85 0.0251 0.0252 0.0279
M  1
I  2
D  3
60
60
60
59.88
59.90
60.03
99.80
99.83
100.06
99.90 0.1422 0.1423 0.0158
H  1
I  2
G  3
H
60
60
60
59.73
59.64
59.76
99.55
99.40
99.60
99.52 0.1041 0.1045 0.0115
* Mean of six observations
TABLE-26
RECOVERY STUDIES OF 50% PREANALYZED FORMULATION
(FINECEF-AM TAB) BY RP-HPLC
Drug %
Amount
present*
(µg mL-1)
Amount
added*
(µg mL-1)
Amount
estimated*
(µg mL-1)
Amount
recovered*
(µg mL-1)
%
Recovery* S.D.
%
R.S.D. S.E.
CEF
80
100
120
100
100
100
10
20
30
109.13
119.33
129.14
9.9290
20.1310
29.9360
99.29
100.65
99.79
0.6878 0.6885 0.0764
Mean 99.91
AMB
80
100
120
60
60
60
6
12
18
65.84
71.73
77.92
5.9880
11.8790
18.0680
99.81
98.99
100.38
0.6987 0.7006 0.0776
Mean 99.72
*Mean of Three observations
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